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ABBREVIATIONS 
FUra, B-flxioronracil; FUrd, 5-fluor©uridine 
FCyd, 5-fluorocytidine 
Ado, adenosine; Cyd, cytidine; Guo, guanosine; Urd, uridine 
7 Drd, dihydrouridine; m Guo, 7-methylguanosine 
4 
rTh.d, ribothymidine; s Urd, 4-thiouridine 
(^rd, pseudouridine; Cm, 2 ' - O-methylcytidine 
NME, nuclear magnetic resonance 
DEAE, diethylaminoethyl 
BD-cellulose, benzoylated DEAE-cellulose 
ED TA, ethylenediaminetetraacetic acid 
Tris -HCl, 2 -amino -2- hydroxymethyl-1, 3 -propanediol hydrochloride 
HEPES, N-2-hydroxyethyIpiperazine-N'-2-ethanesulfonic acid 
POPOP, 1,4-bis [2- (5-phenyloxalyl)] benzene 
PPO, 2,5-diphenyloxazole 
TLC, thin-layer chromatography 
HPLC, high pressure liquid chromatography 
bicine, N, K -^bis (2 -hydroxyethyl)g\ycine 
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INTRODUCTION 
Transfer RNA substituted with the uracil analog 5-fluorouracil 
can be used as a tool both for the investigation of the role of modified nu­
cleosides in tRNA function and for NMR studies of tRNA structure 
and tRNA-protein interactions. When incorporated into tRNA, 5-fluoro­
uracil replaces uridine-derived modified nucleosides as well as uridine. 
Studies of FUra-substituted tRNA may reveal changes in structure or 
activity that can be attributed to the absence of modified uridine resi-
19 dues. ~ F NMR should be particularly useful in studying tRNA-protein 
interactions. Because they contain no fluorine, proteins contribute no 
resonances to ^^F NMR spectra thus simplifying interpretation. 
Hie purpose of this study was to obtain highly purified FUra-
substituted initiator tRNA from Escherichia coli, to characterize it, 
19 
and to obtain a F NMR spectrum. In previous studies, FUra-substi­
tuted valine tRNA has been isolated and characterized (Horowitz et al., 
iq 1974; Ofengand et al. , 1974), and F NMR spectra have been obtained 
(Horowitz at al., 1977). Methionine tRNA s were chosen for further ex­
periments for several reasons. The special role of tRNA^^^ in the ini­
tiation of protein synthesis makes it particularly interesting. There 
are well-established procedures for isolating highly purified normal 
tRNAj from coli (Nishimura, 1971). There are also procedures 
2 
for purifying methionyl-tRNA synthetase (Fayat et al", , 1977V and, par» 
ticularly useful for NMR studies, for obtaining an active tryptic frag­
ment of methionyl-tRNA synthetase (Cassio and Waller, 1971). Line-
widths in an NMR are determined in part by tumbling time and thus 
the molecular weight of the compound being examined. High molec­
ular weight samples will have broad poorly resolved resonances, and a 
reduction in molecular weight will increase spectral resolution (Leigh, 
1976). 
Transfer RNA 
General structure 
_ 
When Holley et al. (1965) first sequenced yeast tRNA , he proposed 
as a possible secondary structure a clover leaf arrangement of the poly­
nucleotide chain. A large number of tRNAs have been sequenced since, 
and all can be arranged into the same general cloverleaf pattern 
(Figure la). The clove rleaf consists of the amino acid acceptor stem 
and four arms. The acceptor stem is made up of the 5' and 3' ends of 
the tRNA. In most tRNAs the first seven residues of the 5' end are base 
paired to complementary nucleosides near the 3" end. In prokaryotic 
initiator tRNAs the first residue of the 5' end is not base paired. Ex­
tending beyond the base-paired region on the 3' end are 4 nucleosides, 
the last three always being -CCA-OH. When the tRNA is charged, the 
3 
amino acid is esterified to the 2' or 3' OH of the 3' terminal adenosine. 
On the left of Figure la is the D arm which is made up of a short 
base-paired (3 or 4 base pairs) stem and a nonbase-paired loop. The 
loop varies in size at the two locations labeled a and , and it usually 
contains one or more dihydrouridine residues for which the arm is 
named. The anticodon arm contains a stem of 5 base pairs and a loop 
with 7 residues including the three that make up the anticodon. Usually^ 
the residue on the 3' side of the anticodon is uridine and that on the 5' 
side is a purine that is often hypermodified. 
The extra (or variable) arm varies in size, containing from 3 to 
21 nucleoside residues. The last arm is named after the sequence that 
is found in that loop in elongator tRNAs and prokaryotic initiator tRNAs, 
T ^ C. As indicated in Figure la, some tRNAs contain modified uridine 
residues other than thymidine in the first position of the loop. Eukary-
otic initiators contain the sequence AUG instead of U* 0 C, and cell-wall 
tRNA^^^ contains UGC. The T stem always contains 5 base pairs. 
In addition to the general cloverleaf outline. Figure la shows sev­
eral invariant or semi-invariant positions. Invariant positions almost 
always contain that particular residue regardless of the specificity or 
source of the tRNA. Semi-invariant positions are ones that almost always 
contain a purine (R) or a pyrimidine (Y). Starred nucleosides are ones 
that are usually modified. Most tRNAs have nucleotide sequences that fit 
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Figure 1; Structure of tRNA. (a) Generalized cloverleaf structure of 
tRNAs. Invariant positions are indicated by nucleoside sym­
bols; semi-invariant positions are designated by R for purine 
and Y for pyrimidine. Positions that often contain modified 
nucleosides are starred, (b) Schematic diagram of the 
Phe tertiary structure of yeast tRNA . (c) Cloverleaf structure 
of E. coli tRNA^^^. The numbering system used is that of 
Gauss et al., (1979). 
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the pattern shown in Figure la. Initiator tRNAs, which will be discussed 
in more d'et^i in a later section, differ in several ways, tRNAs that are 
not used for ribosome-directed protein synthesis show even greater deviar 
tions from the general pattern. Cell wall tRNAGly from Staphylococcus 
epidermidis has UU in place of the usual G*G in the D loop, has C on 
the 3' side of the anticodon instead of a hypermodified purine, and has 
UGC in place of U* C in the T ^  C loop. Although tRNAs with special 
roles differ from the general pattern, all sequenced tRNAs have a pri­
mary structure that can form the basic cloverleaf. The main structural 
features of tRNA are discussed in a review by Clark (1978). 
Solution of the three-dimensional structure of yeast tRNA^® by 
x-ray crystallography (Ladner et al., 1975; Quigley et al., 1975) re­
vealed an L shaped folding of the molecule (Figure lb) with the 3' end of 
the acceptor stem at one end of the L and the anticodon loop at the other. 
The base-paired acceptor and T <1>C stems form a continuous right-handed 
double helix that makes up one leg of the L. The other leg consists of a 
helix formed from the D stem and anticodon stem with the axis of the 
anticodon stem tilted about 20° relative to that of the D stem. The T ^  C 
loop and D loop interact to form the corner of the L. Even though the 
loop regions are not double-helical, their bases are involved in stacking 
interactions. In fact; only 5 of the 76 bases in yeast tRNA^® are not 
stacked (Rich, 1977). The shaped conformation is also stabilized by 
6 
several tertiary interactions, many involving invariant or semi-invari­
ant positions in the D, T 0 C, and variable arms. For example, in yeast 
Phe 
tRNA , G18 and G19 in. the D loop hydrogen bond to ^55 and C56 
respectively in the T C loop. The tertiary interactions between 
bases are rarely of the Watson-Crick type. Many tertiary interactions 
involve hydrogen bonds to oxygen in ribose or phosphate such as the hy­
drogen bond between N-1 of A21 and 0-2' of U8. 
Does the crystal structure of yeast tRNA^^® also represent the 
solution structure? Do all tRNA s assume this general conformation? 
The answer to both questions appears to be yes. A variety of methods 
have been used to study the solution structure of tRNA, including chemi­
cal reactivity of bases (Rhodes, 1975), proton NMR (Reid, 1981), 
nuclease cleavage patterns (Auron et al., 1982), and laser light scat-
Phe tering (Potts et al., 1981). Results of these studies with yeast tRNA 
and with other tRNAs indicate that the L-shaped conformation with 
minor differences is also the structure of tRNA in solution. The crys-
Met Glv 
tal structures of yeast tRNAf (Schevitz et al., 1979), yeast tRNA 
(Wright et al., 1979), yeast tRNA"^^^ (Moras et al., 1980), and E. coli 
tRNAj (Woo et al., 1980) have been determined and the structures 
Phe 
are similar to that of yeast tRNA 
Function 
Transfer RNAs serve as the carriers of amino acids in protein 
7 
synthesis and provide the link between nucleic acid structure and pro­
tein structure. The following is a brief description of the role of tRNA 
in protein synthesis in bacteria (prokaryotic organisms). For a more 
detailed review, see Pongs (1978). 
There is at least one tRNA for each of the twenty amino acids 
utilized in protein synthesis, and frequently there are several tRNAs 
for a given amino acid (isoaccepting tRNA species). There is also a 
specific aminoacyl-tRNA synthetase responsible for forming the ester 
bond between the amino acid and its cognate tRNA (s). The amino acid 
is esterified specifically to either the 2' or 3' hydroxyl group of the 
ribose on the 3' terminal adenosine of the tRNA (Hecht, 1979). 
Once a tRNA has been charged with it specific amino acid, the 
aminoacyl-tRNA can complex with a protein elongation factor (EF-Tu) 
and G TP. This ternary complex binds to the appropriate site on the 
ribosome, the A-site, from which it will be attached to the carboxy-
terminus of the lengthening peptide chain. Selection of the specific 
aminoacyl-tRNA bound is determined by base pairing between the anti-
codon of the tRNA and the complementary codon of ribosome-bound mes­
senger RNA. The peptide chain to which the amino acid on the tRNA in 
the A-site will become attached is covalently bound (esterified) to a tRNA 
on an adjacent ribosomal site called the P-site. A new peptide is 
formed when the a-amino group of the aminoacyl-tRNA attacks the 
8 
carboxyl group of the tRNA-bound peptide chain, in a reaction catalyzed 
by a peptidyl transferase activity associated with the large (50S) ribo-
soRial subunit. The reaction frees the tRNA at the P-site and transfers 
the growing peptide chain to the tRNA at the A-site. Peptidyl-tRNA is 
then translocated to the P-site and Ûie entire elongation process is re­
peated until a termination codon appears in the mRNA. 
Protein synthesis begins with binding of a special initiator tRNA, 
tRNAf , to the small, 30S, ribosomal subunit in response to initia­
tion codons, usually AUG or GUG, in the mRNA. Three proteins 
called initiation factors (IF-1, IF-2, IF-3) aid in formation of the methionyV 
tRNAf -mRNA-30S ribosome initiation complex. In E. coli . IF-3 shifts 
the equilibrium between 70S ribosomes and 3OS and 50S ribosomal sub-
units in the direction of dissociation to subunits, which are required for 
initiation. It also mediates the binding of mRNA to the 3OS subunit. 
IF-1 and IF-2 in the presence of G TP mediate the binding of methionyl-
Met 
tRNAf to the mRNA-30S subunit complex. In prokaryotes, the methionyl-
Met 
tRNAf must be formylated in order to function in initiation. Methionyl-
tRNA transformylase transfers a formyl group from 10-formyltetra-
hydrofolate to the amino group of methionine after the metitiionine is es-
terified to tRNAf . Hydrolysis of GTP and release of the initiation 
factors allows binding of a 50S ribosomal subunit to the tRNA-mRNA-
3OS initiation complex forming a 70S-initiation complex with N-formyl-
9 
Met 
methionyl-tRNAf bound at the P-site. The anticodon of the bound initi­
ator tRNA is base paired to the initiation codon of the mRNA, Codon-
dependent binding to the A-site of the next aminoacyl-tRNA then takes 
place and a peptide bond is formed between the carboxyl group of N-
formylmethionine and the amino group of the aminoacyl-tRNA at the A-
site. Peptide chain elongation then proceeds by the steps outlined. 
There are normally no tRNAs with anticodons complementary to 
the three termination codons, UAA, UGA, and UAG, so when one of 
these appears at the A-site, no aminoacyl-tRNA is bound. Instead, a 
releasing factor binds to the ribosome and the peptidyl-tRNA is hydro-
lyzed, releasing free polypetide and the tRNA from the ribosome. The 
70S ribosome can now dissociate, and a new round of protein synthesis 
can be initiated. 
In addition to their role in protein synthesis, tRNA molecules have 
several other functions. They are important in regulating amino acid 
biosynthetic opérons. For example, transcription of the coU. 
tryptophan operon is regulated by the concentration of tryptophanyl-
Trp 
tRNA . The aminoacyl-tRNA is required for translation of a 
peptide coded by a leader region, rich in tryptophan codons, that precedes 
the first structural gene of the trp operon. As RNA polymerase trans­
cribes the leader region, ribosome s bind to and translate the resulting 
message. When the level of tryptophan and therefore tryptophanyl-
10 
tRNA^^^ is low, the ribosome stalls at a tryptophan codon. The .presence 
of the ribosome alters the mRNA conformation and prevents formation of a 
particular stem and loop conformation that signals transcription termina­
tion (attenuation). RNA polymerase can then continue to transcribe the 
structural genes (Yanofsky, 1981). 
In quite a different role, cellular tRNAs act as primers for DNA 
synthesis by reverse transcriptase of tumor viruses (Harada et al., 
1975). There are also special tRNAs that transfer amino acids in non-
ribosome directed reactions such as the tRNA^^^ required for cell wall 
synthesis in Staphylococcus epidermidis (Roberts, 1972). For more com-
" 
plete list of the functions of tRNA,see the review by LaRossa and Soil 
(1978). 
In the process of carrying out their numerous roles, tRNA interact 
with many different enzymes and proteins. Some of these proteins, such 
as aminoacyl-tRNA synthetase, are very specific in that they generally 
recognize only one tRNA or one group of isoacceptors. Others, such 
as EF-Tu, must recognize many different aminoacyl-tRNAs. In addition 
to the proteins just mentioned, tRNAs interact with processing enzymes 
that cut the primary transcript - the RNA that is initially transcribed 
from DNA and that contains sequences not present in mature tRNA, 
modification enzymes that modify specific nucleoside residues in the 
11 
polynucleotide, tRNA nucleotidyl transferase which repairs missing 
3'-CCA ends, transformylase which formylates methionyl-tRNAj 
ribosomal proteins such as SI which binds formylmethionyl_tRNA^ 
and aids in formation of the initiation complex, and numerous others. 
How an enzyme or protein recognizes a specific tRNA or group of 
tRNA s is not yet clear. 
Methionine tRNA 
In ^  coli as in all other cells, there are two types of methionine 
tRNAs. The initiator tRNA^ places methionine at the N-terminal po­
sition of proteins. Unlike aminoacyl-tRNAs responsible for elongation 
of the growing peptide chain, prokaryotic and mitochondrial methionyl-
tRNAs£ are formylated at the «-amino group of methionine. The reac­
tion, catalyzed by a specific transformylase, occurs after aminoacylation 
Met 
of the tRNA^ and requires 10-formyltetrahydrofolate as the formyl 
xvlet donor. The initiator tRNA^'^ recognizes not only the methionine codon 
AUG, but also GUG and UUG (Marcker and Sanger, 1964; Marcker, 
1965; Clark and Marcker, 1966). 
Methionine residues that occur internally in proteins are brought 
Met . . Met 
to the ribosome by tRNA^ . Methionyl-tRNA^ is not formylated 
by transformylase and recognizes only the AUG codon (Clark and Marcker, 
_ 
1966).  Both tRNAf are aminoacylated by the same aminoacyl-tRNA 
12 
synthetase (Heinrikson and Hartley, (1967). 
As mentioned previously, the structures of initiator tRNAs differ 
somewhat from the general pattern shown in Figure la. In prokaryotic 
initiator tRNA% the 5-terminal base is not base paired (Figure Ic). 
Eukaryotic initiator tRNAs differ from elongator tRNAs and from pro-
karyotic initiator tRNAs, The sequence GT found in the T ^  C-loop 
of most tRNAs is replaced by GAUC, and an A replaces the semi-invari­
ant pyrimidine usually found at the 3' end position of the T loop, 
ïàikaryotic initiator tRNAs are not formylated in vivo, although most 
can be formylated in vitro by the ^ coli transformylase (Haaelkorn 
and Rothman-Denes, 19*73). There is some evidence that the presence 
of ribothymidine in the T ^ C loop necessitates the formylation of initia­
tor tRNAs. When Streptococcus faecalis is grown in the absence of 
folate, which it requires for the methylation of uracil, tRNAf does 
not contain ribothymi dine and can function in the initiation of protein 
synthesis without formylation (Samuel and Rabinowitz, 1974; Delk 
and Rabinowitz, 1975). 
The crystal structure of ^ coU tRNA^®^ reveals some interesting 
differences from the three-dimensional structure of yeast tRNA^^® 
(Woo et al., 1980). The free 3' end of the amino acid acceptor stem is 
curved back over the helix formed by the acceptor and T ^  C stems. The 
Met 
a - region of the D-loop of the tRNAg has one more residue than 
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tRNA^^®. The increased size of the P-loop is accommodated by a 
tighter packing of the residues in this region and not by an increase in size;-. 
Most significantly, a difference in the orientation of the uridine a da-
cent to the 5' end of the anticodon gives the anticodon loop of tRNAf 
a different conformation. Results of SI nuclease digestion of initiator 
tRNA from E. coli, yeasty and human placenta are in agreement with 
an altered anticodon loop conformation in tRNA^®' and indicate that 
this conformation may be a characteristic of initiator tRNA s (Wrede 
et al., 1979). 
Modified nucleosides 
One of the characteristics of tPNAs that distinguishes them from 
other nucleic acids is the large number and wide variety of modified 
nucleosides that they contain. Many of these modifications are simple, 
such as methylation of uridine to ribothymidine; others are quite com­
plex, such as conversion of adenosine to N-(N-(9- 0 -D-ribofuranosyl-
purin -6-yl) carbamoyl] threonine (abbreviated t^A). See Figure 2a 
Ivl fit for the structure of modified nucleosides that occur in ^  coli tRNAf . 
Modified nucleosides generally occur at specific positions in tRNAs 
(See Figure la) (Mc Clos key and Nishia&ura, 1977). 
Precursor tRNA is synthesized from the four common ribonu­
cleotides: ATP, G TP, U TP and C TP. With the exception of queuosine 
14 
which is inserted into tRNA in place of guanine by a transglycosylase, 
modifications take place at the polynucleotide level and are part of the 
processing required to convert the primary transcription product to an 
active tRNA (Agris and Soil, 1977). One enzyme is probably responsible 
for a given modification at a specific site in all tRNAs. For example, 
one transferase is responsible for the synthesis of ribothymidine in the 
T ^ C loop of all E. coli tRNAs (Greenberg and Dudock, 1980). How­
ever, the same modification at different sites in the same tRNA may 
require different enzymes (Green et al. , 1982). 
The functions of modified nucleosides have been the subject of num­
erous studies, and there are several recent reviews of the subject (Agris 
and Soil, 1977; McCloskey and Nishimura, 1977; Nishimura, 1978). 
Perhaps the most interesting conclusion that can be drawn is that few of 
the modifications appear to be essential for cell survival. 
The GT ^  C sequence may be involved in binding of tRNA to the A-
site of the ribosome (Sprinzl et al. , 1976); however, ribothymidine 
and pseudouridine apparently are not essential for this function since 
Val 
FUra-substituted E. coli tRNA] containing the sequence GFFC 
has been found to perform as well as normal tRNA^^^ in EF-Tu-GTP-
aminoacyl-tRNA complex formation, ribosome binding, and in vitro 
polypeptide synthesis (Ofengand et al. , 1974). An E. coli mutant lack­
ing ribothymidine in its tRNA is able to grow normally although it can 
15 
riboa* ribos* ribose 
4-thiouridine dihydrouriditie ribothymidine 
ribos* 
ribosa 
pseudouridine 7-methylguanosine 
b 
H 
5 - fluorouracil 
Figure 2: Structures, (a) Modified nucleosides found in ^  coli 
Met 
tRNA£ . (b) 5-Fluorouracil. 
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be overgrown by the wild type when the two are cultured together 
(Bjork and Neidhardt, 1975). 
The residue on the 3' side of the anticodon is frequently a hyper-
modified purine and appears to aid in correct codon recognition 
(Nishimura, 1978). N^-isopentenyladenosine (i^A) is often found in 
this position if the tRNA recognizes a codon starting with U, and N-
(^-( /5-r-ribofuranosylpurin-6-yl)rcarbamoy3 threonine (t^A) is often 
adjacent to the anticodon if the tRNA recognizes a codon starting with 
A. TRNA s that recognize codons starting with C or G usually have 
methylated A or G next to the anticodon. coli tRNA^®^ contains t^A 
-
in this position and recognizes only the codon AUG. E. coli tRNA^ 
contains unmodified A and recognizes GUG and UUG as well as AUG. 
T&ere is evidence that loss of the modification adjacent to the anticodon 
destroys the amino acid transfer ability of some tRNA s (Gefter and 
Russell, 1969; Miller et al., 1976). 
The first position of the anticodon also often contains a modified 
nucleoside. This position was named the "wobble position" by Crick 
(1966) because, unlike the other two anticodon nucleosides, the nucleo­
side occupying this position may recognize more than one codon base. 
For example, a uridine residue in the first position can pair with G as 
well as A and guanosine can pair with both G and U. Some modified 
nucleosides also recognize more than one base. Inosine in the first 
17 
position can pair with U, C, or A in the third position of the codon, and 
uridine-5-oxyacetic acid can pair with A, G, or U. The first anti-
Val 
codon position of ^ coUtRNA^ contains uridine-5-oxyacetic acid, 
and thus this tRNA recognizes three valine codons: GUU, QUA, and 
Val GUG. It is interesting to note that FUra-substituted tRNAj^ which has 
much of it uridine-5-oxyacetic acid replaced by fluorouridine (Horowitz 
Val 
et al., 1974), is somewhat less effective than normal tRNA^ in poly 
(G, U)-dependent in vitro polypeptide synthesis (Ramberg et al., 1978). 
Val 
If 5-fluorouridine is read as uridine, then analog-substituted tRNAj 
would recognize GUA and GUG but not GUU and would be less effective 
in translation of a poly (G, U) message. 
Sometimes the modification of a first position anticodon nucleo­
side results in strict reading of the codon. 2-Thiouridine, unlike un­
modified uridine, recognizes only A (Nishimura, 1978). 
The regulation in Salmonella typhimurium of the biosynthesis 
of certain amino acids, such as histidine and leucine, involves their 
cognate tRNA s (Lewis and Ames, 1972; Cortese et al. , 1974). his T 
mutants of ^  typhimurium lack pseudouridine synthetase I, the 
enzyme that forms pseudouridine in the anticodon stem and loop of 
tRNAs. Transfer RNAs lacking pseudouridine in this region are no 
longer effective in the regulation of amino acid biosynthesis, and these 
mutants have de repressed levels of histidine, leucine, and isoleucine-
18 
valine biosynthetic enzymes fTurnboueh- et al. ,. 1979), The modifica­
tion of uridine to pseudouridine appears to be essential to the regula­
tory function, of these tRNAs. 
The methylated nucleosides ribothymidine, 7-methylguanosine, 
and 2'-0-methyIcytidine are not essential for tRNA^®^ activity (Marmor 
Met 
et al., 1971) since methyl-deficient tRNAf from a mutant E. coli 
can be aminoacylated and fprmylated to the same extent as normal 
Met 
tRNAf although the rate of aminoacylation is lower. Triplet direct­
ed ribosome binding, and Qfi RNA directed dipeptide synthesis are the 
same for methyl-deficient and normal tRNA^ . Since methyl-deficient 
Met Met 
tRNA^ is bound by elongation factor but methyl-deficient tRNA^ is 
not, lack of methylated nucleosides does not prevent discrimination 
between the two (Marmor et al. , 1971). 
Met 
Partially purifiedc o l i  tRNAf treated with sodium borohydride 
to reduce dihydrouridine and 4-thiouridine retained over 80% of its 
acyl acceptance activity (Shugart and Stulberg, 1969). 
_ Met 
There are six modified nucleosides in E. coli tRNAf (Figure Ic), 
and the experiments described above indicate that probably none of them 
is essential for aminoacylation. The effect of these modified nucleosides 
on tRNA structure and function are probably subtle. Some of their sug­
gested functions (Nishimura, 1978) such as stabilization of conformation 
or increased resistance to nuclease activity would not be easily detected 
by in vitro assays of airdnoacylation or protein synthesis. 
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Effects of 5-Fluor©uracil 
5-Fluorouracil (FUra) (Figure 2b) was first synthesized as a pos­
sible anti-cancer agent (Duschinsky et al. , 1957). Preliminary studies 
demonstrated activity against transplanted tumors in rats and mice 
(Heidelberger et al., 1958). There are several reviews of the early 
studies with the analog: effects of incorporation into cells (Heidel­
berger, 1965), effects of replacement of uridine in RNA (Mandel, 
1969), and clinical use (Heidelberger and Ansfield, 1963). The gener­
al effects of FUra on cells include inhibition of PNA synthesis as a 
result of inhibition of thymidine synthesis by FdUMP and reduction 
of RNA synthesis with incorporation of the analog into RNA in place 
or uridine. Protein synthesis continues, but at a reduced rate. 
Furthermore, bacterial cell wall synthesis is inhibited (Tomasz and 
Borek, I960). Several of the effects of FUra can be reversed in some 
cells by addition of uracil and/or thymidine (Heidelberger et al., 1957 
Cohen et al., 1958). 
Metabolism 
The metabolically active forms of 5 - fluor ouracil are the nucleo­
tides FUTP and FdUMP, FUra and fluorouridine are known to be 
converted to nucleotides by the normal pyrimidine salvage pathways of 
tumor cells (Skold, 1958; Chaudari et al. , 1958; Bosch et al., 1958\, 
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mouse tissue (Chaudhuri et al., 1958) and bacterial cells (Cohen et al. , 
1958; Brockman et al., I960). In addition to being metabolized by the 
pyrimidine salvage, pathways, fluoropyrimidine nucleosides act as 
feedback inhibitors of de novo pyrimidine synthesis. Two enzymes 
in this pathway have been shown to be inhibited by fluorouridine and 
fluorodeoxyuridine. Aspartate transcarbamylase from rat is in­
hibited by fluoropyrimidine nucleosides although not as effectively as 
by the natural nucleosides (Bresnick, 1962a; Bresnick, 1962b), Di-
hydroorotase from Novikoff asites hepatoma is similary inhibited 
(Bresnick and Blatchford, 1964). 
Tumors that are resistant to FUra treatment are almost always 
lacking enzymes of the pyrimidine salvage pathways and are unable to 
convert FUra to nucleotides (Kessel et al. , 1966; Goldberg et al. , 1966; 
Kessel et al. , 1971; Wilkinson and Crumley,. 1977). 
Effects on DNA synthesis and dTMP synthesis 
E. coli does not synthesize DNA after addition of FUra to the 
culture (Cohen et al., 1958). Addition of thymidine partially reverses 
the inhibition but addition of uracil has no effect. (Cohen et al., 1958* 
Horowitz et al. , I960). Studies with several kinds of eukaryotic cells 
as well as E. coli show the inability to synthesize DNA in the FUra-
treated cells is due to inhibition of thymidine synthesis (Heidelberger 
et ai, 1957; Danneberg et al. , 1958; Bosch et al. , 1958; Harbers et al., 
1959). Thymidylate synthetase, which catalyzes the methylation of the 
C5 of dUMP, is inhibited by FdUMp (Cohen et al. , 1958; Hartmann and 
Heidelberger, 1961). 5-Fluorouracil and 5-fluorouridine do not inhibit 
the enzyme, but they are metabolized by the cell to FdTJMP which is an 
analog of the normal substrate dUMP. 
FdUMp has been a valuable tool in the study of the mechanism, of 
thymidylate synthetase activity. Inactivation of thymidylate synthetase 
is due to formation of a ternary complex between FdUMP, the enzyme 
and the cofactor involved, 5, lO-methylenetetrahydrofolate. The 
enzyme becomes bound to the 6-position of the pyrimidine ring and the 
cofactor is covalently attached to carbon 5 (Santi and McHenry, 1972; 
La.ngenbach et al. , 1972). This complex is believed to be analogous 
to that formed with the natural substrate and is stable because of the 
19 inability to remove the F from the pyrimidine ring, F NMR studies of 
FdUMp-inhibited enzyme have provided detailed information on the 
structure and sterochemistry of the thymidylate synthetase reaction 
(Byrd et al. , 1977; Byrd et al. , 1978; Lewis et al. , 1980), 
Early studies found no evidence for the incorporation of FUra into 
cellular DNA (Chaudhuri et al. , 1958; Horowitz and Char gaff, 1959). 
FdUTP can act as a substrate for in vitro DNA synthesis catalyzed by 
calf thymus DNA polymerases a or 0 (Tanaka et al. , 1981), and re­
cently FdUrd has been found in the DNA of FUra-treated bacterial 
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cells and mammalian cells in culture (Kufe et al,, 1981; Warner and 
Rockstroh, 1980; Danneberg et al., 1981. Probably the analog is 
observed in the DNA of FUra-treated cells only rarely because it is re­
moved by the same series of reactions responsible for eliminating 
uracil from DNA (Warner and Rockstroh, 1980), FdUTP is a substrate 
for deoxyuridine triphosphate diphosphohydrolase which normally hydro-
lyzes dUTP. Furthermore, FdUrd-containing DNA is a substrate for 
uracil-DNA glycosylase which cleaves the N-glycosydic bond of deoxy­
uridine residues (Ingraham et al., 1980). 
Incorporation into RNA and effects on ribosomes 
Treatment of mice or suspensions of Ehrlich ascites cells with 
FUra results in incorporation of the analog into RNA (Heidelberger 
et al., 1957; Bosch et al., 1958). Similarly, analysis of RNA isolated ficm 
FUra-treated ^  coli shows incorporation of FUrd in place of uridine 
(Horowitz and Chargaff, 1959). 
5-Fluorouracil is also incorporated into RNA viruses such as 
tobacco mosaic virus (Gordon and Staehelin, 1958), polio virus (Munyon 
and Salzman, 1962), bacteriophage f2 (Cooper ani Zinder, 1962) and 
bacteriophage MS-2 (Shimura and Nathans, 1964). 
Cells grown on FUra are no longer able to synthesize normal ribo­
somes. FUra-treated bacteria accumulate abnormal ribosomal par­
ticles (A ronson, 1961; Hahn and Mandel, 1971). In eukaryotic cells, 
FUra-substituted rRNA is not completely processed (Hadjiolova et al», 
1973; Wilkinson, et al., 1975; Rungger and Grippa, 1977), The effects 
of FUra incorporation into RNA and ribosomes have been reviewed by 
Mandel (1969). 
It has been, generally assumed that the main source of the anti­
tumor activity of FUra is the inhibition of thymidylate synthetase. 
Recent evidence indicates that in at least some cases incorporation of 
FUra into RNA is of equal or greater importance. For example, the ef­
fectiveness of FUra against a mammary tumor and a colon tumor of 
mice is increased when deoxythymidine is administered with the analog 
(Nayak et al., 1978; Spiegelman et al., 1980). The deoxythymidine 
partially reverses the inhibition of DNA synthesis and greater uptake of 
FUra into RNA is observed. Studies have shown a significant correla­
tion between FUra incorporation into RNA and anti-tumor activity 
(Sawyer et al. , 1979; Evans et al. , 1980: Kufe and Major, 1981),. 
Effect on messenger RNA and protein synthesis 
FUra is also incorporated into mRNA (Gros et al. , 1961) and pro­
tein synthesis continues in FUra-treated ^  coli (Horowitz et al. , 1958), 
The effect of FUra incorporation into mRNA on protein composition 
has been examined in several ways, including incorporation of specific 
amino acids into total protein (Harbers et al. , 1958; Aronson, 1961) in 
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vitro translation with. FUra-substituted mRNA (Soffer, 1964; Carrico 
and Glazer, 1979) and in vitro translation with poly (FU) and poly (U, FU) 
(Wahba et al., 1963; Grunberg-Manage and Michels on, 1964). These 
studies indicate that the incorporation of FUra into mRNA generally 
does not affect the composition of protein subsequently synthesized. 
There is some evidence that FUra is misread as cytidine either 
during translation or during transcription. Phenotypic reversion 
of rll mutants of T4 phage (Champe and Benzer, 1962) and of amber muta­
tions of ^ coli alkaline phosphatase (Rosen et al., 1969) has been at­
tributed to mistranslation of FUra-substituted mRNA. There is some 
evidence of mistranscription of DNA when FUTP is used in place of UTP 
(Kahan and Hurwitz, 1962; Glazer and Legraverend, 19^0). No evidence 
has been found of misreading as cytidine during in vitro translation 
with poly (FU) and poly (FU, U) (Grunberg-Manago and Michels on, 1964). 
FUra-substituted tRNA 
Studies of FUra-substituted transfer RNA have been conducted to 
determine whether replacement of uridine by 5-fluorouridine alters the 
structure and/ or activity of these molecules. Since uridine-derived 
modified nucleosides are also replaced by the analog, FUra-substituted 
tRNAs provide an opportunity to investigate the function of some of 
these nucleosides. 
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Early studies of tRNA from FUra-treated E. coli (Lowrie and 
Bergquist, 1968; Johnson et al., 1969; Kaiser et al., 1969a) showed a 
much lower pseudouridine, 5, 6-dihydrouridine, and ribothymidine con­
tent compared to normal tRNA. Kaiser (1969b; 1972) also studied the 
thiobase composition of tRNA from FUra-treated ^  coli. 5-Methyl-
ami nomethyl-2-thi our idine is almost completely absent, and 4-
thiouridine and 2-thiocytidine are found in reduced amounts. The level 
of 2 -methylthio-N^ - ( A ^ -isopentenyI) adenosine is unaffected by the 
analog. There is no evidence of thiolation of FUrd (Kaiser, 1972). 
5-fluorocytidine is found in FUra-substituted tRNA and replaces about 
6% cytidine in FUra-substituted tRNA^^^ (Kaiser and Kwong, 1973; 
Horowitz et al., 1974). The level of uridine-5-oxyacetic acid in FUra 
tRNA^^^ is 26% of the level in normal tRNA^^ (Horowitz et al., 1974). 
The effect of FUra incorporation on modified uridines is not re­
stricted to coli. Reduced amounts of ribothymidine, dihydr©uri­
dine, and pseudouridine have been found in FUra-substituted RNA from 
rat liver (Wagner and Heidelberger, 1962), mouse liver (Lu et al., 1976), 
Saccharomyces cerevisiae (Giege et al,, (1969a, b); Kaiser, 1971b) and 
Bacillus subtilus (Kaiser and Kladianos, 1981), In most cases, the con­
tent of modified nucleosides derived from nucleosides other than uri­
dine is unchanged by incorporation of FUra into RNA; however, reduced 
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levels of methylated purines have been found in FUra-tRNA from 
Saccharomyces cerevisiae (Johnson et al., 1980) and L1210 cells 
(Glazer and Harfanan, 1980). 
The reduced amounts of ribothymidine, pseudouridine, and 
dihydrouridine in FUra-substituted tRNA are not simply due to the 
fluorine blocking the 5 position and preventing modification of fluoro-
uridine residues. The per cent decrease in these nucleosides can be 
much greater than the per cent replacement of Urd by FUrd (Baliga et 
al. , 1969; Lu et al., 1976; Tseng et al., 1978; Frendewey and Kaiser 
1979; Kaiser and Kladianos, 1981). Although this could be due to pref­
erential incorporation of FUrd into positions that would normally be 
modified, Frendewey and Kaiser (1979) have found that in tRNA with 
very low levels of FXJrd (less than 4 mole %) the decrease in modified 
nucleosides is greater than the FUrd incorporated and the levels of 
uridine in the tRNA actually increases. These results indicate that 
FUra or its metabolites inhibit the synthesis of minor bases. Fren­
dewey et al., (1982) have recently reported evidence that FUra-substi-
tuted tRNAs are inhibitors of pseudouridine synthetase and ribothy­
midine methyl transferase and that the inhibition involves very tight 
binding of FUra-tRNA to the enzymes. However, Gotten and Horowitz 
(personal communication. Dept. of Biochemistry, Iowa State Univ. ) 
have evidence of the modification of a fluorouridine residue in 
Met 
FUra-substituted tRNAf to dihyd r ofluo rouridine. 
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Many of the differences in physical properties that are observed 
between normal and FUra-tRNA are attributed to the increase of the 
acidity of the hydrogen at N-3 of FUra due to the presence of electro­
negative fluorine at the 5 position. 5-Fluorouridine has a pKa of 7.57 
while uridine has a pKa of 9. 25 ( Wempen et al., 1961). At physiolog­
ical pH almost half of the FUrd residues in FUra-substituted tENA are 
ionized at N-3, whereas very few of the uridine residues in normal 
tRNA are ionized. 
Structural studies of poly-5 -fluorouridylic acid show it to be, like 
poly (U), a random coil at room temperature in the presence of Mg"^"*" at 
pH 7, but at low temperatures poly (U) under goes a transition to a more 
ordered structure (T^=6. 6°C), whereas poly (FU) does not (Szer and 
Shugar, 1963; Massoulie et al., 1966). Poly (FU) can form double and 
triple-stranded complexes with poly (A). The double-stranded helix is 
only slightly less stable than the helix formed from poly (U); however, 
the poly (FU) complex reversibly dissociates at pH 3, and the poly (U) 
complex is stable to pH 9. 5 (Szer and Shugar, 1963). The dissociation 
pH is close to the pKa of the pyrimidine residues in the polynucleotide 
in both cases. 
Consistent with the observations made with homopolymers, the 
structural properties of FUra-substituted tRNA are similar to those of 
normal tRNA. Kaiser (1971a) examined unfractionated FUra-tRNA from 
E. coli by UV-temperature measurements, ribonuclease degradation. 
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gel filtration, and sucrose gradients and found only small differences 
++ 
from normal tRNA at pH 7 with or without Mg . At pH 8. 8, where 
FUrd residues are almost completely ionized, the differences are greateç 
and the FUra-tRNA seems more open and less compact than normal 
tRNA. Further studies (Moore and Kaiser, 1977) have shown a hyper-
chromic effect for FUra-tRNAs on increasing pH from 7 to 9, indicat­
ing disruption of secondary and tertiary structure. 
Studies with purified FUra-substituted valine tRNA from E. coli 
(Horowitz et al. , 1974) again show the FUra-tRNA to have physical 
Val properties very similar to normal tRNA . Only minor differences 
are found in the melting profiles, circular dichroism spectra, and elec-
trophoretic mobilities in polyacrylamide gels. The FUra-substituted 
tRNA^^^ did have a decreased hypochromicity in the absence of Mg"'"'" 
Val 
at pH 7.4 compared to normal tRNA » 
The substitution of 5 -fluorouridine for uridine in tRNA does not seem 
to cause any major changes in secondary or tertiary structure at pH 7. 
Since uridine-derived minor nucleosides are absent from these mole­
cules, they must not be essential for forming or maintaining the correct 
conformation. 
FUra-substituted tRNAs are a useful tool in investigating the in­
volvement of uridine and modified uridine residues in the various tRNA-
protein interactions required for tRNA function. Because of its 
importance and ease of assay.the aminoacylation reaction of FUra-tRNA 
has been the most studied. Transfer RNA isolated from FUra-treated 
E. coli retains the ability to accept all twenty amino acids although the 
extent of reaction may vary from the control (Lowrie and Bergquest, 
1968; Johnson et al., 1969; Kaiser, 1969a; Ramberg et al., 1978). 
FUra-substituted tRNAs from yeast were also found to accept all 
eighteen amino acids tested (Giege et al., 1969b). The kinetics of 
Val 
charging has been determined for purified FUra-substituted tRNA 
The Km for valyl-tRNA synthetase is about the same for both FUra and 
Val 
normal tRNA , but the V^^^ is 15% lower for the FUra-substituted 
tRNA. 
Although there is acceptance activity for all amino acids by FUra-
tRNA, the rate of aminoacylation for some amino acids is much lower 
than the rate with normal tRNA (Ramberg et al. , 1978). Aspartate, 
glutamate, glutamine, histidine, and lysine FUra-tRNAs have amino­
acylation rated less than half of normal, with lysine at 6% of normal 
having by far the greatest reduction. The codons for these five amino 
acids have adenosine in the middle position and therefore a fluorouri-
dine in the anticodon of the tRNA. Since the anticodon region is involved 
in synthetase recognition for some tRNAs (Schimmel, 1979), the pres­
ence of one or more fluorouridine residues may affect the RNA-protein 
interaction. FUra-substituted lysine tRNA, which has the lowest rate of 
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aminoacylation, has three fluorouridine residues in the anticodon re-
5 2 placing the normal mam S UUU anticodon sequence. 
Aminoacylation of FUra-tRNA is more sensitive to pH changes than 
aminoacylation of normal tRNA (Moore and Kaiser, 1977). Increasing 
the pH of the reaction from 7 to 9 decreases the rate and extent of 
charging. These effects are probably due to changes in structure at 
high pH mentioned in the previous section. 
FUra-substituted tRNAs are able to function in protein synthesis 
in vitro, but as in aminoacylation some tRNAs are as active as normal 
tRNA while others are much less active. Amino acid incorporation into 
peptide occurs at normal levels with ^  coli FUra-tRNA^® and poly 
(U) but at reduced levels with E. coli FUra-tRNA^^^ and poly (A) 
(Ramberg et al., 1978). Use of the natural messengers phage R17 or 
phage f2 in tRNA dependent in vitro systems results in lower levels of 
incorporation than found with synthetic messengers; in £act Low rie and 
Bergquist {1968") found no incorporation of lysine with FUra-substituted 
tRNA^^ and phage R17. Similar results were obtained using tRNA 
from FUra-treated yeast (Giege et al. , 1969b). Polynucleotide-direct­
ed ribosome binding of E. coli tRNA is unaffected by FUra substitution in 
valyl-, phenylalanyl-, and glycyl-tRNA but is greatly reduced by FUra 
substitution in lysyl- and glutamyl-tRNA (Ramberg et al. , 1978). 
31 
Val Studies with FUra-substituted tRNA from ^  coli , the only 
purified FUra-tRNA whose ability to function in protein synthesis has 
been examined, show little difference between FUra and normal tRNA 
(Ofengand et al. , 1974). Ternary complex formation with EFTu - GTP, 
non-enzymatic binding to the ribosome P-site, enzymatic binding to the 
ribosome A-site, and polypetide synthesis are essentially the same in 
rate and extent when FUra-tRNA^^^ replaces normal tBNA^^\ 
These studies clearly demonstrate that the presence of uridine 
derived modified nucleosides is not essential for tRNA activity in 
aminoacylation or in vitro protein synthesis. 
19 
F NMR of FUra-substituted RNA 
Pure highly substituted FUra-tRNA species are excellent subjects 
iq iq 1 13 for F NMR studies. 'F nuclei have several advantages over H, C, 
31 15 P, or N for NMR studies of biopolymers (Sykes and Hull, 1978; 
19 1 Gerig, 1978). The sensitivity of F NMR is 83% of H and far greater 
13 15 19 _ 19 
than C or N, and the natural abundance of F is 100%. F NMR 
has a large range of chemical shifts compared to proton NMR, and they 
are more sensitive to the nucleus environment. There are only 12 - 14 
fluorines in an FUra-substituted tRNA compared to a very large number 
1 
of protons. H NMR is limited to the upfield resonances due to methyl 
and methylene protons and the far downfield resonances due to 
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19 
hydrogen-bonded ring NH protons in base-paired regions. F res-
19 
onances can be observed from F located in any region of the tRNA. 
Although assignment of resonances will be difficult, it should be possible 
to eventually associate each NMR signal with a specific fluorine in the 
tRNA. 
19 Val A F NMR spectrum of FUra-substituted tRNA from coli 
has been obtained (Horowitz et al., 1977). Eleven peaks and two 
shoulders are resolved. Although the resonances cannot yet be assigned 
specifically to the 14 fluorouridine residues of tRNA^^\ preliminary 
work indicates that downfield resonances may correspond to the three 
residues with tertiary hydrogen bonds and upfield resonances to the 
residues with secondary hydrogen bonds, Heat denaturation of unfrac­
tionated FUra-substituted 5sRNA (Marshall and Smith, 1977) results 
in the spectrum collapsing to a single peak at 5 ppm. This suggests 
that resonances around 5 ppm from non-denatured FXJra-RNA are due 
to non-hydrogen bonded FUra residues. Since the resonances downfield 
from 5 ppm are the first to disappear on heating of unfractionated FUra 
substituted tRNA (Cohn et al. , 1981), they are likely due to tertiary 
interactions. 
In the study that follows, highly purified FUra-substituted 
Met 
tRNAf was obtained and resolved into two forms during the last puri­
fication step. Both forms were readily aminoacylated and formylated. 
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There were differences in the RNase Tj oligonucleotide maps of the 
Met 
two forms. Some of the properties of the two forms of FUra-tRNA^ 
19 
were examined and F NMR spectra were obtained. FUra-substituted 
Met 
tRNAjjj^ was also partially purified. 
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EXPERIMENTAL PROCEDURES 
Mate riais 
E. coli tRNA was purchased from Schwarz/Mann or Plenum Re-
Met 
search. Purified ^  coli tRNAf was obtained from Boehringer Mann­
heim Biochemicals. Radioactive amino acids were purchased from New 
England Nuclear or ICN pharmaceuticals, and tritium-labeled KBH^ was 
from Amer sham Corp. ^ coli B was supplied by Grain Processing 
Company, Muscatine, Iowa. 5-Fluorouracil was a gift of Hoffman-La-
Roche. Calcium leucovorin was donated by Lederle Laboratories. Seph-
adex G-25, Sephacryl S-200, DEAE-Sephadex A-50, and Sepharose 4B 
were purchased from Pharmacia. DEAE-cellulose was obtained from 
Whatman. Biorad was the source of BD-cellulose and phosphocellulose. 
Cellulose thin-layer sheets (20x20 cm) were from E. M. Laboratories, 
and polyethyleneimine thin-layer sheets (20x40 cm. Polygram CEL 
300 PEI) were purchased from Brinkmann Instruments. Ribonuclease 
Ti, Tg, and A were obtained from Sigma Chemical Corporation. Bac­
terial alkaline phosphatase and snake venom phosphodiesterase were 
from Worthington Biochemical Corporation. Highly purified bacterial 
alkaline phosphatase from Bethesda Research Laboratories was used 
in the preparation of RNase Tj fingerprints. The purified methionyl-
tRNA synthetase, prepared by the method of Fay at et al. (1977), was a 
gift from Mildred Cohn. Eastman-Kodak X-Omat R film XR-5 was 
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used for fluorography. 
To minimize nuclease activity all glassware was baked at 140°c 
for 6 h or longer and water was autoclaved. Dialysis tubing was pre­
pared for use by first boiling for 30 min in a solution of 6 mM ED TA, 
16 mM sodium bicarbonate, and 0.5% v/v ^-mercaptoethanol and then 
boiling 30 min in water. The tubing was soaked in several changes of 
fresh water and stored at 4°C. Acrylamide and bis-aery lamide were re-
crystallized from chloroform and acetone respectively. Phenol was 
distilled and stored at 4°C protected from light. 
Methods 
Growth of E. coli on 5-Fluorouracil 
E. coli B was grown on a minimal glucose-salts medium (Demerec 
and Cahn, 1953) at 37°C in 15 L batches aerated by bubbling prewarmed -
air through the cultures. When the cells had reached log phase, 5-
fluorouracil and thymidine were added to the culture to a concentration 
of 25 mg/L each. Incubation was continued for 3 h. Dow Medical Anti-
foam AF Emulsion, 2. 5% v/v in 95% ethanol was added in 20 mL por­
tions /15L as needed to prevent foaming. Cells were collected with a 
Sharpies continuous flow centrifuge, washed two times with 10 mM Tris-
HCl, pH 7.4, 10 mM MgCl2, and stored at -20°C. The yield was 
20 - 35 g of cells/15 L culture. 
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Preparation of tRNA 
RNA was extracted with phenol directly from whole cells by the 
method of Zubay (1966). Thawed ^  coll cells were suspended at a con­
centration of 0. 5 g/mL in 1 mM Tris-HCl, pH 7.4, 10 mM magnesium 
acetate. After the addition of 0. 86 volumes of 90% phenol, the suspen­
sion was shaken for 2 h at room temperature and the emulsion was broken 
by centrifugation for 10 min at 10, 000 X g. The aqueous layer was saved 
while the phenol layer and thick layer of cell debris were washed with 
buffer; then the aqueous layers were combined. The phenol layer was 
discarded and the thick layer of cell debris was re-extracted with fresh 
phenol for 1 h. The aqueous layer from the second extraction was com­
bined with that from the first, and the RNA was precipitated by addition 
of 0. 1 volume of 20% potassium acetate, pH 5, and 2 volumes of cold 
95% ethanol. After collecting the precipitate and dissolving the RKA in 
1 mM Tris-KCl, pK 7.4, 10 mM magnesium acetate, the RNA solu­
tion was shaken with an equal volume of 90% phenol for 30 min. The 
emulsion was broken by centrifugation and the phenol layer washed as 
described above. The phenol extraction procedure was repeated two or 
three times until no fluffy layer was seen at the phenol-H20 interface. 
Following the final phenol treatment the RNA was precipitated from the 
aqueous layer with ethanol and dissolved at a concentration of 2. 5 mg/mL 
in 300 mM sodium acetate, pH 7. 0. RNA concentration was determined 
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0. 1% 
from the absorbance at 260 nm using a value of ^2^0 ~ 24. 
A major portion of the high molecular weight ribosomal RNA was 
removed from the preparation by isopropyl alcohol treatment (Zubay, 
1966). Addition of 0. 54 volumes isopropyl alcohol at 20°C to the RNA 
solution precipitated the high molecular weight RNA. The precipitated 
RNA was collected by centrifugation and dissolved in 300 mM sodium 
acetate, pH 7. 0. Ribosomal RNA was again precipitated by addition of 
0.54 volumes of isopropyl alcohol at 20°C. After centrifugation at 
20°C, the supernatant was combined with the first supernatant and RNA 
was precipitated by addition of 0. 23 volumes of isopropyl alcohol at 
.20°C. 
Transfer RNA was separated from 5S rRNA and from any remaining 
high molecular weight RNA by chromatography on a 2, 5x235 cm.Sepha-
cryl S-200 column at room temperature. About 400 mg of RNA, dis­
solved at a concentration of 20 - 30 mg/mL- in 0. 5 NaCl, 0, 14 M sodiuir; 
acetate buffer, pH 4. 5, was applied to the column and eluted with the 
same buffer. Fractions of 4 mL were collected at a flow rate of 0.7 
mL/min. 
Purification of FUra-substituted initiator cRNA 
FUra-substituted tRNA^^^ was purified by a series of chroma­
tographic steps. At each step^ the fractions containing methionine tRNA 
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were located by amino acid acceptance assay. 
DEAE-cellulose FUra-substituted tRNA was separated from 
normal tRNA on a DEAE-cellulose column at pH 8, 9 as described by 
Kaiser (1969a). A 2,5x90 cm column was used to fractionate 500 - 700 mg 
of tRNA. The tRNA was applied at a concentration of 2. 5 mg/mL in 
20 mM Tris-HCl, pH 8,9, containing 0.2 MNaCl, and was eluted 
with an 8 L concave gradient of NaCl from 0. 325 M to 0. 6 M prepared 
in the same buffer. The column was run at room temperature at a 
flow rate of 2 mL/min, Fractions of 25 mL were collected in test tubes 
containing 0. 33 mL of 20% potassium acetate, pH 5, to lower the pH. 
The pooled methionine tRNA-containing fractions were assayed for 
formylatability to distinguish between initiator and non-initiator 
methionine tRNA. 
The high pH required for fractionation on the DEAE-cellulose 
column deacylated any charged tRNA present so that it was not neces­
sary to include a separate deacylation (stripping) step in the isolation 
procedure. 
Met 
Sepharose 4B FUra-substituted tRNAf from the DEAE-cel­
lulose column was fractionated further on a 2x94 cm Sepharose 4B col­
umn using a reverse salt gradient (Holmes et al. , 1975; Colantuoni 
et al. , 1978). About 400 mg of tRNA dissolved at a concentration of 10 
mg/mL in a buffer containing 10 mM sodium acetate, pH 4. 5, 10 mM 
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MgClg, and 1. 5 M ammonium sulfate, was applied to the column 
equilibrated with the same buffer. The tRNA was eluted with a 3 L 
linear reverse gradient of ammonium sulfate from 1.5 M to zero. Col­
umns were run at 4°C at a flow rate of 0, 7 mL/min and 12 mL fractions 
were collected. The pooled tRNA^^^ containing fractions were dia-
lyzed against several changes of water at 4°C to remove amimonium sul­
fate before the RNA was recovered by ethanol precipitation. 
DEAE-Sephadex A-50 Further fractionation of FUra-substi-
Met 
tuted tRNAf was carried out on a 1.5x160 cm DEAE-Sephadex A-50 
column at room temperature (Nishimura, 1971). A sample of 1600 -
3000 6/^7 - 125 mg), at a concentration of 100 - 200 Ag^o''™-^» 
in 20 mM Tris-HCl, pH 7. 5, containing 8 mtM MgC I2 and 0. 18 M 
NaCl, was applied to a column equilibrated with the same buffer con­
taining 0.425 M Nad. RNA was eluted with a 1.8 L linear gradient of 
NaCl from 0.425 to 0. 50 M. Fractions of 8 mL were collected at a flow 
rate of 0. 1 to 0. 2 mL/min. 
BD-cellulose BD cellulose (Gillam et al. , 1967) was used for the 
final step in the purification of FUra- substituted tRNA^^^. A 0. 9x120 
cm column was equilibrated at 4°C with 10 mM sodium acetate, pH 4. 5, 
10 mM MgCl2, 0.40 M NaCl. A solution of 600 - 800 
(25 - 33 mg) of RNA was applied to this column at a concentration of 
40 A26o/"^L* The column was developed with a 650 mL linear gradient 
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of NaCl from, 0.40 M to 0.76 M, and 3 mL fractions were collected at 
a flow rate of 15 mL/h, 
Analytical columns of BD-cellulose with dimensions of 0,7x69 cm 
were also used. The amount of RNA applied to these columns varied 
from 5 to 15 A260 units and 1 mL fractions were collected at a flow rate 
of 12 mL/h. Development of the column was the same as described for 
the preparative column except that the volume of the gradient was re­
duced in proportion to the column volume. On occasion,analytical col­
umns were developed with a linear gradient of NaCl from 0.4 to 1. 0 M. 
Met 
Purification of FUra-substituted tRNArm 
Met 
FUra-substituted tRNA^ , separated from the initiator methio­
nine tRNA by chromatography on DEAE-cellulose, was partially puri­
fied by the same chromatographic procedures used for the purification 
Met 
of FTJra-tRNAf . The sample was first chromatographed on a 
Sepharose 4B column and then on DEAE-Sephadex A-50. The latter 
column was developed with a 3. 6 L linear gradient of NaCl from 0.425 
to 0. 575 M. A sample of 100 A260 units of FUra-substituted tRNA^^^ 
was chromatographed on an analytical BD cellulose column developed 
with a 300 mL linear gradient of NaCl from 0. 4 to 1.0 M. 
Amino acid acceptance assay 
The ability of tRNA to accept amino acids was determined in a 
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reaction mixture containing, in a total volume of 100 /iL; 100 mM 
HE PES, pH7.5, lOmMKCl, 10 mM ATP, 1 mM dithiothreitol, 20 
mM magnesium acetate, 60 - 80 mM radioactive amino acid (either 
14 3 C-labeled, specific activity ca. 50 nCi/ A*mole or H-labeled, spe­
cific activity 200 - 500 MCi/^Lmole), 300 Mg/mL partially purified 
aminoacyl-tRNA synthetases, and 1-20 -^2^0^^^ tRNA. The mixture 
was incubated for 30 min at 37°C, and the reaction was then stopped by 
addition of 2 mL 5% trichloracetic acid. After standing 10-30 min in 
the cold, the precipitate was collected on Millipore filters and washed 
2 times with cold 5% trichloroacet acid. The filters were dried under a 
heat lamp, and counted in the toluene based scintillation cocktail contain­
ing 0.5% (w/v PPO and 0.0% (w/v) POPOP, in a Beckman LS 3150T 
or LS 7500 liquid scintillation counter. 
Column fractions assayed for amino acid acceptance often con­
tained high concentrations of NaCl (0. 3 -1.0 M). Preliminary experi­
ments showed that aminoacylation of FUra-substituted tRNA (but not 
normal tRNA) with methionine was inhibited by salt. There was a linear 
decrease in the level of charging in the range of salt concentrations 
examined (zero to 0. 4M), and a NaCl concentration of 0.35 M was 
sufficient to reduce the level of charging 50%. Consequently,the ob­
served specific activity of methionine tRNA when assayed in column frac­
tions containing NaCl was lower than the specific activity of the same 
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tRNA after it was pooled and freed of NaCl. 
Aminoacyl-tRNA synthetases were partially purified to remove 
tRNA and nucleases by the procedure of Muench and Berg (1966), 
E. coli cells were broken with a French pressure cell and the paste sus­
pended in 10 mM Tris-HCl, pH 8.0, 10 mM ;MgCl2, and 10% glycerol. 
Cell debris were removed by centrifugation at 27, 000 x g for 30 min. 
After centrifugation at 97,300 x g for 6 h to remove ribosomes, the 
supernatant was chromatographed on.aDEAE-cellulose column equili­
brated with 20mM potassium phosphate, pH 7,5, containing 1 mM 
MgGl^-, 20 mM j)-mercaptoethanol, and 10% glycerol. The column was 
washed with the same buffer until the Aggg was below 0. 06, and the 
aminoacyl-tRNA synthetases were then eluted with 250 mM potassium 
phosphate, pH 6.5. A^gg absorbing material was pooled, placed in 
dialysis tubing, and surrounded by solid polyethylene glycol 6000 to 
concentrate the solution. The partially purified synthetase preparation 
was stored at -70°C. 
When large amounts of aminoacylated tRNA were needed, a scaled 
up reaction mixture was used. Charged tRNA was isolated from the re­
action mixture by the method of Vickers and Logan (1972). The 
aminoacyl-tRNA was bound to DEAE-cellulose by shaking the RNA with 
a slurry of DEAE-cellulose suspended in 0. 1 M sodium acetate, pH. 5, 
containing 0. 1 M NaCl. Unbound material was removed by washing 
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the DEAE-cellulose several times with the buffer. Bound RNA was 
recovered by washing with 1 M NaCl in 0. 1 sodium acetate, pH 5. 
Deacylation (stripping) of charged tRNA was accomplished by in­
cubating the aminoacyl-tRNA at 37°C for 30 min in 1 M Tris-HCl, 
pH 9, (He ne s, et al., 1969). 
Kinetics of methionyl-tRNAf formation 
For kinetic studies with purified methionyl-tRNA synthetase, 
tRNA was aminoacylated in a 100 mL reaction mixture containing 40 
mM HEPES, pH 7.5, 150 mM KCl, ZmMATP, 1 mM dithiothreitol, 
7 mM magnesium acetate, 0. 1 mM ED TA, 0. 1 mg/mL bovine serum 
albumin, 80 fiM. methionine (51.4 mCi/mmole), 180 pM purified 
methionyl-tRNA synthetase and various concentrations of tRNA 
(Blanquet, et al. , 1973). Purified methionyl-tRNA synthetase (Fayat, 
et al. , 1977) was generously provided by Dr. Mildred Cohn (Depart­
ment of Biochemistry and Biophysics, University of Pennsylvania). 
Reaction mixtures were preincubated for 1 min at 25°C before enzyme 
was added. The rate of aminoacylation was linear for more than 10 
min and incubations were routinely run for 5 min to 10 min depending 
on RNA concentration. The reaction was stopped by addition of 2 mL 
of cold 5% trichloroacetic acid, and the precipitates were collected and 
counted as described for the amino acid acceptance assay. Prelimi­
nary experiments showed that the rate of aminoacylation was linear 
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under these conditions and that the values obtained represented 
initial charging rates. 
Formylation assay 
The formylation assay was based on the observation by Schofield 
and Zamecnik (1968)that 10 mM Cu^"^ at pH 5. 5 catalyzes the hydroly­
sis of aminoacyl-tRNA but not that of N-acylated aminoacyl-tENA. 
When methionine tRNAs are charged in the presence of a formyl donor 
and then treated with a solution of Cu'^'*' at pH 5. 5, formylmethionyl-
^^Gt îvlet 
tRNAf is stable, but methionyl-tRNA^ , which cannot be formy-
lated, is rapidly hydrolyzed. This is illustrated in Figure 3 which 
shows the kinetics of hydrolysis of unfractionated tBNA charged with 
methionine in the presence of 10-formyItetrahydrofolate. (Trans-
formylase is present in the crude enzyme preparation used for aminoa-
cylation.) In the example shown, the hydrolysis with Cu^^ reached a 
plateau in about 8 min. The material resistent to hydrolyses at this 
time was formylmethionyl-tENAf (74% of the methionine tRNA in 
the sample used for Figure 2). Hydrolysis in 1. 8 M Tris-acetate, pH 8, 
which deacylates both unsubstituted and formylated methionyl-tRNA, was 
run as a control. 
To assay for the per cent tRNAf present in a sample, the tP.NA 
was charged in the presence of 10-formyltetrahydrofolate and a portion 
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Figure 3: Kinetics of hydrolysis of methionyl-tRNA, A sample of 
unfractionated tRNA was charged with cj methionine in 
the presence of 10-formyItetrahydrofolate and then hydrolyzed 
with 10 mM CuSO^ in 0, 2 M sodium acetate, pH 5. 5 (•——•) 
or 1.8 M Tris-acetate, pH 8. 0 ( o o). The results are ex­
pressed as a percentage of the original radioactivity remain­
ing precipitable with 5% TCA. 
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incubated with Cu^^ for 20 mi a a time more than sufficient to allow for 
complete hydrolysis of unformylated methionyl-tBNA (see Figure 3). 
The tRNA sample was aminoacylated in a 500 mL reaction mixture 
containing, in addition to the usual components, 600 M 10-formyl-
tetrahydrofolate. After incubation for 30 min at 37°C, duplicate 100 mL 
aliquots were treated with 5% trichloroacetric acid. To the remaining 
solution an equal volume of 20 mM CuSO^ in 0.4 M sodium acetate, 
pH 5. 5, was added and incubation was continued for 20 min at 37°C. 
At that time 5% trichloroacetic acid was added to duplicate 200 mL 
aliquots of the reaction mixture and both sets of samples were prepared 
and counted as described in the amino acid acceptance assay. The aver­
age of the duplicate samples taken before and after incubation with Cu^^ 
were used to calculate the fraction of methionine tRNA present at 
Met 
tRNAf . 
Samples charged in the absence of lO-formyltetrahydrofolate and 
then incubated in Cu^^ solution were expected to be 100% hydrolyzed, but 
in practice hydrolysi s was never complete leaving 1 - 20% of the 
methionyl-tRNA unhydrolyzed. Incomplete hydrolysis was not due to the 
presence of 10-formyltetrahydrofolate in the crude enzyme preparations 
used since enzyme freed of low molecular weight contaminants by 
chromatography on Sephadex G-25 gave similar results. Lysyl-tRNA^^® 
also was not completely stripped in 10 mM Cu"^"^ at pH 5. 5. Corrections 
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for this incomplete hydrolysis were made in calculating the extent of 
formylation by subtracting the counts of the control sample, charged in 
the absence of the formyl donor and then hydrolyzed with Cu"^, from 
the counts of the formylated samples taken before and after Cu^"*^ 
hydrolysis, 
10-Formyltetrahydrofolate was prepared from calcium leucovorin 
(5-formyltetrahydrofolate) as described by Dubnoff and Maitra (1971). 
Calcium leucovorin was first converted to 5, 10-methenyltetrahydro-
folate by incubation for 3. 5 h with 0. 1 M HCl. The product was stored 
at -20°C and converted to 10-formyItetrahydrofolate by treatment with 
0. 08 M KOH, 0. 04 M Tris-HCl, pH 7. 8, just prior to use. 
Polyacrylamide gel electrophoresis 
Electrophoresis was run in 104x130x0.5 mm gel slabs at room 
temperature. The gels were composed of 10% or 15% polyac rylamide 
and were prepared from solutions containing acrylamide and 
bisacrylamide, in a 20:1 ratio; in 20 mM Tris-acetate buffer, pH 8.0, 
containing 1 mM ED TA (Rubin, 1973). Denaturing gels contained, in ad­
dition, 7M urea. The RNA samples (0.5 - 5 /tg) were applied to each 
sample well in a volume of 20 uL, containing 20% (w/v) sucrose, 0.025% 
(w/v) bromophenol blue and, where appropriate, 7M urea. Electrophore­
sis was carried out at 12 mA, in the same buffer used for gel preparation. 
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until the bromophenol blue marker reached the end of the gel (3 toi5 h). 
Gels were stained overnight in 1% (w/v) Pyronin prepared in 15% (v/v) 
acetic acid, and de stained by immersion in several changes of 7, 5% 
(v/v) acetic acid. 
Analysis of nucleoside composition 
Nucleoside composition of RNA preparations was determined by a 
tritium derivatization method (Randerath et al,, 1972; Bande rath et al., 
1974) or by HPLC (Davis et al., 1979). The HPLC analyses were per­
formed by Drs. Charles Gehrke and Paul Agris, and Mr, Kenneth Kuo 
at the University of Missouri by reverse-phase chromatography of 
nucleosides on a 600x4 mm ^Bondpack C^g column. 
The first step in the tritium-derivative method was hydrolysis of 
the RNA to nucleosides. RNA was dissolved in a total volume of 10 
/iL containing 30 mM sodium bicine, pH 8. 0, 10 mM MgClg, 0. 2 
pg/ mL ribonuclease A, 0.2 iigf |iL snake venom phosphodiesterase, 
and 0. 16 tig I aiL bacterial alkaline phosphatase, and the mixture was 
incubated at 37°C for 6 h, A 4 ^ L aliquot of the digest was oxidized to 
a mixture of nucleoside dialdehydes by reaction with 1.2 mM sodium 
periodate for 2 h in the dark at room temperature; the total reaction vol­
ume was 20 /iL. Reduction of the dialdehydes to the nucleoside 
trialcohols was carried out by cooling the sample briefly on ice, adding 
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potassium phosphate, pH 6. 8, to a concentration of 14 mM, and incu-
3 bating with 10 mM H-labeled KBH^, 3 Ci/mmole, for 2 h in the dark at 
room temperature in a volume of 25 /iL, Addition of 30 <iL of 2 N 
acetic acid stopped the reaction and destroyed excess KBH^. The 
samples were thenevaporated to dryness overnight in a vacuum desic­
cator over NaOH. 
The resulting nucleoside trialcohols were taken up in 10 /iL of 
0. 1 M formic acid and separated by two-dimensional TLC on 20x20 cm 
sheets of cellulose. Development in the first dimension was with a 
freshly prepared mixture of acetonitrile, ethyl acetate, 1-butanol, 
2-propanol, 6 N NH4OH (7:2:1:1:2.7). After the cellulose sheet was 
dried, a 6 cm Whatman #1 paper wick was stapled to the top of the plate 
in the second dimension. The solvent for the second dimension, ^-amyl 
alcohol, methyl ethyl ketone, acetonitrile, ethyl acetate, H2O, formic 
acid (40:20:14:20:14:1.8), was run to within 0.5 cm of the top of the 
wick. 
The location of the separated nucleoside trialcohols was determined 
by fluorography (Randerath and Randerath, 1971). Chromatograms 
were coated with PPO by pouring 14 mL of a 7% solution in diethyl 
ether over each cellulose sheet. Coated chromatograms were stapled 
to x-ray film (Eastman-Kodak X-Omat R), and the film was exposed 
for 24 - 28 h at -70°C. The developed film was used to locate the 
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position of nucleoside trialcohols on the chromatogram. These were 
cut out and eluted from the cellulose sheet overnight with 2 M NH^OH. 
Aliquot s of the eluant were counted in a scintillation cocktail containing 
25% (v/v) Triton X-114, 0. 3% (w/v) PPO, 0» 02% (w/v) POPOP in xylene. 
Recovery of the trialcohol of 7-methylguanosine is only 64% by this pro­
cedure (Randerath et al., 1972), and calculation of nucleoside composi­
tion were corrected accordingly. 
RNase Tl-alkaline phosphatase fingerprints 
Oligonucleotide maps of tRNA preparations were prepared by tri­
tium-derivative methods described by Randerath et al., (1980), but the 
procedures were modified to allow the use of commercially prepared 
polyethyleneimine-cellulose TLC sheets (Chem and Roe, 1978) and of 
lower specific activity tritiated KBH4. 
Transfer RNA was digested for 90 min at 37°C in a solution con­
taining i itgi iiL, RNA, 50 units/ uL, RNase T^, 2 units/ /«L highly puri­
fied bacterial alkaline phosphatase (Bethesda Research Laboratory) and 
50 mM sodium bicine, pH 7. 8, in a total volume of 12 <iL. The resulting 
oligonucleotides were labeled at the 3' end by periodate oxidation followed 
3 3 
by reduction to the H-labeled dialcohols with K-labeled KaH^. A digest 
was incubated at room temperature in the dark for 2 h with 6 mM 
3 NalO^ and then 2 h in 75 mM H-labeled KBH4, 4. 3 Ci/mmole. Excess 
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KBH^ was destroyed with 2 M acetic acid, the samples were dried in 
vacuo, and the residues were taken up in 20 iiL water. 
Oligonucleotide maps were prepared by two-dimensional TLC on 
polyethyleneimine (PEI) cellulose. PEI-cellulose sheets were washed 
prior to use with 10% NaCl and then with water. The plates were stored 
at -20°C until used (Banderath and Randerath, 1966). For chromatog­
raphy the sample (20 /iL) was applied in small portions 2 cm from the 
lower lefthand corner of a 31x20 cm pretreated PEI-celluloe e sheet. The 
sheet was first irrigated with 4 M lithium formate, pH 3.5, 7 M urea 
until the solvent front reached a distance of 5 cm from the bottom of the 
sheet to separate radioactive contaminants from the sample. After the 
sheet was soaked in methanol: ammonia (1000:1) for 10 min and dried, 
the lower 3 cm of the sheet were cut off and discarded. The chromato-
gram was then developed in the first dimension for 2 cm with water and 
then with increasing concentrations of LiCl as follows: 0.1 M to 5 cm; 
0.2 M to 11 cm; 0.35 M to 21 cm; 0. 6 M to 28 cm^op). Dried chromato-
grams were washed twice in methanol for 10 min. Development in the 
second dimension was with increasing concentrations of ammonium form­
ate, pH 3. 1, as follows : 0. 1 M to 2 cm; 0. 8 M to 7 cm; 1.2 M to 12 cm; 
1.6 M to 15 cm; and 2, 2 M to 20 cm. The chromatograms were dried, 
3 
washed in methanol for 10 min, and dried again. H-labeled oligonucleo­
tides were visualized by fluorography as described for the nucleoside 
analysis and the spots were cut out and counted directly on the cellulose 
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sheet in 2 mL of 0. 5% PPO in toluene. 
The composition of each oligonucleotide was determined by the 
tritium derivative method after elution of the oligonucleotide from the 
TLC sheets. Each spot was washed in methanol and then water to re­
move PPO. The PEI-cellulose coating was then scraped from the plastic 
backing and placed on 3-5 mm phosphocellulose columns prepared in 
Pasteur pipets. Oligonucleotides were eluted by washing the columns 
with two 500 /iL portions of 4 M pyridinium formate, pH 4. 2. The elu-
ent was collected and lyophilized; the residue was taken up in 150-200 
ttlu of water and lyophilized again to remove pyridinium formate. This 
step was repeated once more. 
To hydrolyze the-oligonucleotide, the lyophilized residue was taken 
up to 10 /iL of a solution containing 0, 1 /t//«L ribonuclease T2, 
0. 2 yug//iL bacterial alkaline phosphatase, 20 mM sodium bicine pH 
7.1, and 20 mM MgCl2 and incubated for 2 h at 37°C. The resulting 
3 
nucleosides were converted to the H-labeled trialcohols as described 
earlier except that the concentrations of reagents used in the oxidation 
and reduction were lowered to 0. 24 mM NalO^, 8. 5 mM potassium phos-
3 phate, and 6.8 mM H-labeled KBH^. 
3 
The H-labeled nucleoside trialcohols together with a mixture of un­
labeled trialcohols (10 /imoles each) were applied to a cellulose TLC 
3 
sheet and chromatographed as described earlier. H-labeled nucleoside 
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trialcohols were located by fluorography. These were identified by com­
paring their location on the fluorograms with the position of the known 
unlabeled markers, visualized under an ultraviolet lamp. Unlabeled 
nucleoside trialcohols used as markers were prepared by oxidation with 
periodate and reduction with KBH^ as described by Randerath and 
Banderath (1971). 
NMR 
19 To prepare FUra-substituted tRNA for F NMR spectroscopy, 
samples were dialyzed against water overnight at 4°C and then lyophil-
ized. Six milligrams of the tRNA were dissolved in 1. 5 mL of buffer 
containing 30 mM sodium cacodylate, pH 7.2, 80 mM NaCl, 1 mM ED TA, 
and 10 mM MgCl2. Addition of 0. 3 mL of D2O provided a field fre-
19 quency lock. F NMR spectra were recorded at 169 mHz on a Bruker 
WH-180 spectrometer. Spectra were obtained at 35°C in Fourier trans-
ferm mode. NMR tubes with an outside diameter of 10 mm were used 
with a votex suppressor. The spectra were recorded by Drs. Neville 
Kallenback and Mildred Cohn at The Middle Atlantic NMR Facility at the 
University of Pennsylvania. 
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RESULTS 
Met 
Purification of FUra-Substituted tRNA^ 
Transfer RNA isolated from FUra-treated E. coli contain normal, 
unsubstituted tRNA formed before addition of FUra to the growing cells, 
as well as FUra-substituted tRNA. The first step in the purification of 
specific FUra-substituted tRNAs, therefore, required removal of unsub­
stituted tRNA. This was accomplished by chromatography on a DEAE-
cellulose column at pH 8. 9 with a concave NaCl gradient. Under these 
conditions normal RNA is eluted earlier than FUra-substituted RNA 
(Kaiser, 1969a). As shown in Figure 4, chromatography of unfraction-
ated tRNA from analog-treated ^  coli on DEAE-cellulose resulted in 
two broad peaks of A260 absorbing material. The first one (fractions 
150 to 275) containing mostly normal tRNA was followed by a larger peak 
(fractions 275 to 500) of FUra-substituted tRNA. Two peaks of meth­
ionine accepting activity (fractions 150 to 200 and 200 to 225) were ob­
served in the material eluting below 0.4 M NaCl (unsubstituted tRNA). 
They were eluted close together and early relative to the A260 peak. 
The FUra-substituted fraction also contained two broad peaks of meth­
ionine tRNA (fractions 300 to 370 and 420 to 475). These two peaks were 
widely separated, and the second peak appeared in the trailing portion of 
the A2£,q profile in contrast to the behavior of the normal methionine 
tRNAs. 
s 
O) 
M 3 
i 
ï* 2 
1 
4.0 
3.0 
2.0 
I 
I 
1.0 
300 350 400 
Fraction Number 
Figure 4: Chromatography of F Ura-substituted E. coli tRNA on DEAE-cellulose. Unfractionated 
FU ra - substituted tRNA (10, 250 A^^^ units) was chromatographed on a DEAE-cellulose 
I  
column (2. 5x90 cm) as described in Methods. RNA was eluted from the column with 
a concave NaCl gradient* Fractions were assayed for methionine acceptance activity 
(o—d) and valine acceptance activity (•—•), and Ag^^ (o—o). NaCl concentration 
(A- -A). 
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For comparison, the elution profile of valine tENA, purified pre­
viously {Horowitz et al., 1974),is also shown in Figure 4. The FUra-sub-
stituted tRNA^^^ elutes as a major peak just after the first FUra-tRNA^®^ 
peak; a second small valine tENA peak was also observed. 
The first peak of FUra-substituted methionine tENA (fractions 301 
to 370) was 88% formylatable and, therefore, contained the initiator tENA 
while the second peak (fractions 416 to 475) was not formylatable and con­
tained tENA^®^. Thus,DEAE-cellulose chromatography readily sepa­
rated the FUra-substituted initiator tENA from the non-initiator species. 
In contrast, both peaks of normal methionine tENA contained tENA 
that could be formylated; the ENA of the first peak was 60% formylatable 
and that of the second was 58% formylatable. The fractions containing 
FUra tENAf (301 to 370) and FUra tENA^^^ (416 to 475) were pooled 
separately and further purified. 
Initiator tENA comprised 70% of the total FUra-substituted methio­
nine tENA, consistent with the relative amounts of tENA^®' and tENA^®^ 
found in normal cells (Marcker, 1965). 
Met 
At this stage, the FUra-substituted tENA^ had a specific activity 
of 155 pmole/A-^Q, Substantial further purification was achieved by 
chromatography on Sepharose 4B using a reverse salt gradient from 1. 5 to 
zero ammonium sulfate (Figure 5). Methionine acceptance activity was 
present as an unsymmetrical peak (fractions 135 to 200). The main pool 
Met 
Figure 5; Chromatography of FUra-substituted tRNA^ on Sepharose 4B. Partially purified 
FUra-tRNA (9395 units) recovered from DEAE-cellulose (Figure 4) was frac­
tionated on a Sepharose 4B column (2x49 cm) at 4°C as described in Methods. The 
column was developed with a reverse gradient of ammonium sulfate. The 12 
mL fractions were assayed for methionine acceptance activity (•——•) and Ag^Q 
(  o i>) .  Ammonium sulfate concentration (A A).  
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Figure 6; Chromatography of FUra-subscituted tKNAj on DEAÊ-Sephadex A-50, Partially puri­
fied FUra-tRNAj^^'^ (1600 Ag^g units) was chromatographed on a DEAE-Sephadex A-50 
column (1. 5x157 cm) as described in Methods. The column was developed with a linear 
NaCl gradient. Fraction:: of 8 mL were collected and assayed for methionine acceptance 
(# #) and A26O NaCl concentration (A--A), 
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of FUra-substituted tRNAj (135 to 168) had a specific activity of 660 
pm.ole/A2^Q. trailing shoulder of methionine acceptance activity 
(fractions 169 to 180) was pooled separately. This probably contains a 
methionine tRNA species different from that in the major peak since ad­
dition of this material to another preparation of FUra-substituted tRNA 
and rechromatography on Sepharose 4B showed an increased amount of 
methionine accepting activity in the trailing peak. This material was not 
further purified. 
Met 
The main pool of FUra-substituted tRNA^ from the Sepharose 
4B column was further fractionated by chromatography on DEAE- Sepha-
dex A-50 (Figure 6). Methionine tRNA emerged early in the elution pro­
file. The RNA in fractions 105 to 129 was pooled and was found to have a 
specific activity of 1300 pmole/A2£,o-
Met 
Further purification, of FUra-substituted tRNAg was achieved by a 
final chromatographic step using BD-cellulose. During this procedure. 
Met 
the FUra-tRNA^ was resolved into two components (Figure 7) desig­
nated (A) (fractions 80 to 105) and (B) (fractions 121 to 148). A total of 
412 A260 of purified FUra-substituted tRNA^^^ was recovered: 
213 A2£JQ units of form (A) with a specific activity of 1610 pmole 
/A26O 199 ^2^0 of form (B) with a specific activity of 1552 
pmole/A2(,Q. Both forms of purified FUra-substituted tRNA^®^ could be 
formylated. Our usual assay showed form (A) to be 108% formylatable 
Met 
Figure 7; Separation of two forms of FUra-tRNAf on BD cellulose. Partially purified 
tRNA£ (600 A260) was fractionated on a BD-cellulose column (0. 9x120 cm) as 
described in Methods. The RNA was eluted with a linear NaCl gradient; NaCl 
concentration was increased to I. 5 M at the arrow. Three mL fractions were 
collected and assayed for methionine acceptance activity (e #) and ^2^,0 (0—0). 
NaCl concentration (A--A). 
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Table 1: Summary of purification of FUra-substituted tRNA^ 
Met 
tRNA sp act total tRNA^ Recovery 
(A26O) (pmole/A26o) (pmole) % 
ar Preparation I 
DEAE-cellulose 9400 155 1.46x10^ (100) 
Sepharose 4B 1640 653 1. 07x10^ 73 
Sephadex A-50 551 1404 7. 74x10^ 53 
(A) 213 1610 3.43x10^ 23 
BD-cellulose C 
(B) $99 1552 3. 09x10 21 
Preparation II 
DEAE-cellulose 11328 148 1.68x10^ (100) 
Sepharose 4B 2653 451 1. 20x10^ 71 
Sephadex A-50 876 1154 1. 01x10^ 60 
(A) 230 1459 3. 37x10^ 20 
BD-cellulose 
(B) 380 1443 5. 51x10^ 33 
and form fB) to be 93% formylatable. After this final purification step, 
44% of the methionine acceptance activity present in the FUra-tRNA pool 
following DEAE-cellulose chromatography was recovered. 
The purification is summarized in Table la. Figure 8 shows the gel 
patterns obtained on electrophoresis of samples taken at various steps in 
Figure 8: Polyacrylamide gel electrophoresis of FUra-substituted 
Met 
tRNAf at various stages of purification. Samples were 
electrophoresed as described in Methods on 10%polyacryla­
mide gel prepared in buffer containing 7 M urea. (1) 5 jUg 
of unfractionated tRNA from FUra-treated_E. coli; (2) 
Met 
2 pg FUra-tRNA£ pool from DEAE-cellulose; (3) 2 y/g 
Met 
FUra-tRNA£ pool from Sepharose 4B; (4) 1 ytg FUra-
Met 
tRNA£ pool from DEAE-Sephadex A-50; (5) I jAg FUra-
Met Met 
tRNAf (A) from BD-cellulose; (6) 1 ^ g FUra-tRNAf 
(B) from BD-cellulose. 
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the purification. Electrophoresis was carried out on 10% polyacrylamide 
gels under denaturing conditions (7 M urea). Both forms of the final 
product migrated as single bands. 
Results of a second preparation of FUra-substituted tRNA^ 
are also summarized on Table lb.- Purification at each step was essen­
tially the same as the first preparation. The only significant difference 
between the two preparations was that the second yielded relatively less 
Met 
of the (A) form of FUra-substituted tRNAj . Form (A) made up 53% 
of the tRNA recovered in the first preparation but only 38% of that re­
covered in the second. 
M 
Purification of FUra-Substituted tRNAj^ 
As shown in Figure 4, FTJra-substituted tRNA^^^is well-sepa-
Met 
rated from initiator tRNA^ during the fractionation on DEAE-cellulose. 
Met 
The non-initiator tRNAj^ was further purified by procedures similar to 
those used for FUra-substituted tRNA^®^ pooled FUra-tRNA^^^ from the 
DEAE-cellulose column, specific activity 150 pmole/A2^Q, was 
chromatographed on Sepharose 4B using a reverse salt gradient of 
ammonium sulfate (Figure 9). The methionine acceptance activity was 
eluted from the column as a sharp peak early in the elution profile. The 
recovered tRNA^^^ was purified four-fold to a specific activity of 696 
pmole/Ag^ Q .  
67 
Net 
Table 2; Summary of purification of FUra-substituted tRNA^ 
tRNA sp act Total tRNA^ Recovery 
(Ag^g) (pmole/A26o) (P^^ole) (%) 
DEAE-cellulose 13622 153 2. 08x10^ (100) 
Sepharose 4B 1963 696 1. 37x10^ 66 
Sephadex A-50 648 819 5. 31x10^ 22 
Further fractionation of the FUra-substituted tRNA^®*" was carried 
out on DEAE-Sephadex A-50. Methionine acceptance activity was eluted 
as a broad peak from this column. The elution profile given indication 
of several components (Figure 10), Because the flow rate of the column 
was slow, it required about 2 weeks to complete the run. Recovery of 
A260 absorbing material was high, 96%» but only 59% of the methionine 
accepting activity could be recovered, probably as a result of the pro­
tracted length of the separation. The specific activity of the methionine 
tRNA (fractions 331 to 395) was 819 pmole/A2^Q. Results of the purifi­
cation are summarized in Table 2. No further purification of the FU-
tRNA^ could be obtained by chromatography on either DEAE-Sephadex 
A-25 or RPC-5. 
The behavior of partially purified FUra-substituted tRNA^®^ on 
BD-cellulose was exainined. Like the FUra-substituted initiator tRNA, 
tRNAjY^ was separated into two components by this procedure 't^igure ll\. 
Met Met 
Figure 9; Chromatography of FUra-substituted tRNA^ on Sepharose 4B. FUra-tRNA^ con­
taining fractions (11,800 ^2^0 units) from the DEAE-cellulose column (Figure 4) 
were pooled and chromatographed on Sepharose 4B as described under Methods. The 
column was develope d with a reverse gradient of ammonium sulfate. Ammonium 
sulfate concentration wan dropped to zero at the arrow. The 10 mL. fractions were 
assayed for methionine acceptance activity (# •) and Ag^Q (o—o). Ammonium 
sulfate concentration (A--A). 
Fraction Number 
Figure 10: Chromatography ofFUra- aubstituted tRNÂ^ on. DEAE-Sephadex A-50. Partially 
Met 
purified FUra-tRNA^ (1700 units) was applied on a DEAE-Sephadex A-50 
column and eluted with NaCl as described in Methods. NaCl concentration was 
increased to 1 M at the arrow. Five mL fractions were collected and assayed for 
methionine acceptance activity (•——•) and ^260^o—o). NaCl concentration 
(x- -x) .  
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Figure 11: Separation of two forms of FUra-substituted tRNAj^ on BD cellulose, A  sample 
of the FUra-tRNA^^^'' recovered from Sepharose 4B (100 units) was 
chromatographed on a BD-cellulose column (0. 7x63 cm) as described in the text. 
The column was developed with a linear NaCl gradient; at the arrow elution was 
continued with buffer containing 1, 5 M NaCl and 15% ethanol. One ml, fractions 
were assayed for methionine acceptance activity (# #) and (o—o). NaCl 
concentration (A--j1). 
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Kinetics of Atninoacylation 
Both forms of FUra-substituted initiator tRNA were fully active 
in accepting methionine and were formylatable by methionyl-tRNA 
transformylase, since the purification procedure was based on the abil­
ity to accept methionine and the purified tRNA^^^^ s were fully formylatable. 
The kinetics of aminoacylation were studied to provide a more detailed 
comparison of the interaction of FUra-substituted and normal tRNAs 
with synthetase. 
As a preliminary to the detailed kinetic experiments, the optimal 
ionic conditions for aminoacylation were determined. Reactions were 
run for 5 min. During this time the rate of aminoacylation was linear, 
and each point, thus, represents a rate of charging. As shown in 
Figure lithe maximum rate of charging occurred at 150 irM KCl and at 
Met 
a magnesium ion concentration of 6 to 8 mM. Normal tRNAf and 
both species of the FUra-substituted tRNA had similar optima. The 
values observed are essentially the same as those reported by Blanquet 
et al. (1973). 
Kinetic measurements were made under the optimal ionic condi-
++ 
tions (150 mM KCl and 7 mM Mg ) at 25°C with a synthetase concentra­
tion of 180 pM. Purified methionyl-tRNA snythetasè (Fayat et al., 1977), 
kindly supplied by Dr. Mildred Cohn, was used in these experiments. 
The data are presented as double reciprocal plots in Figure 13. Lines 
F *l"l* f" *1 _ Figure 12; Effect of [Mg J and |KCl j on the rate of aminoacylation of tRNA^ . The tRNA 
(4 / U M )  was aminoacylated as described under Methods in a reaction of mixture 
Met 
that contained 372 pM purified methionyl-tRNA synthetase, (a) normal tRNAj ; 
Met Met (b) FUra-tRNA£ (A); (c) FUra-tRNAf .(B) KCI concentrations used were: 
10 mM (•——•), 75 mM (O—O), 150 mM (o—o), and 300 mM (Ar—û). 
2 4 6 8 10 12 2 4 6 8 10 
[Mg^^J (mM) 
e 5 -
i j-St 
l/PRNA) OiM") 
Figure 13: Kinetics of aminoacylation of tRNA^®'. Transfer RNA preparations were aminoacy-
lated at 25°C as described in Methods. RNA concentration was varied from 0. 5 JÀM to 
5. 0 Lines in the double reciprocal plots were fitted to the data points by a 
weighted linear regression (Wilkinson, 1961; Barnes and Waring, 1980\. (a^ normal 
Met Met Met 
tRNAf ; (h) FUra-tRNAf (A); (c) FUra-tRNAf (BK 
78 
Table 3: Kinetic parameters of aminoacylation of normal and FUra-
siibstituted initiator tHNAs 
Km V 
_1 a 
( u M) (sec ) 
Met 
FUra tRNAf (A) 0.92 + 0.08 5.8 4^0.2 
Met 
FUra tRNAf (B) 0.94 j^O. 13 5.7 4^0.3 
Normal tRNAf 1.7+0.3 6.8 + 0.6 
a 
Values expressed as the number of moles of aminoacyl-RNA formed 
-1 -1 o 
X mole enzyme x sec at 25 C. Enzyme concentration was 180 pM. 
in the figure were fitted to the data points by a weighted linear regres­
sion (Wilkinson, 1961; Barnes and Waring, 1980), and Km and V^^^ 
values were calculated from the lines. Apparent K^s for the two FUra-
substicuted cRNAs were nearly identical and about 45% lower than that for 
Met 
normal tRNAf (Table 3). The turnover rates (V) were slightly lower 
for the analog-containing tRNAs than normal tRNA. Values for and 
Met 
V determined for normal tRNAf were similar to those observed under 
similar conditions by Blanquet et al. (1973), 3.7 /iM and 14.6 mole amino-
- 1  - 1  
acyl tRNA x mole enzyme x sec 
Properties of FUra-Substituted tRNA^^^ 
The properties of FUra-substituted tRNAf^®^s were examined in 
79 
order to compare their composition and structure to that of normal 
Met 
tRNA£ . In addition, the two forms of FUra-tRNA were compared to 
determine how they differed from each other. 
Electrophoretic mobility 
When the purified FUra-substituted tRNA^^^s were examined by 
electrophoresis in 15% polyacrylamide gels under denaturing conditions 
(7 M urea), the two forms were found to migrate slightly more slowly 
than normal tRNA^^^ (Figure 14a; compare lanes 1, 2, and 6). Mixtures 
of normal tRNAf and either species of FUra-tRNA could be resolved 
into two bands by electrophoresis (Figure 14a; lanes 4 and 5). Migra­
tion of form (A) of FUra-substituted tRNA^^^ appeared slightly retarded 
relative to that of form (B), but mixtures of the two could not be clearly 
separated (Figure 14a; lane 3). Even two-dimensional electrophoresis 
on 10 - 20% polyac rylamide gels in a pH 8.3 borate buffer, as described 
by Ikemura and Dahlberg (1973), failed to resolve a mixture of form (A) 
and form (B) (results not shown). 
In other experiments, electrophoresis of the FUra-substituted 
tRNAs was carried out (in 7 M urea) using samples which had been 
heated to ô5^C in 6 M urea for 5 min, conditions that would allow separa­
tion of fragments if the tRNA molecules were nicked. No rapidly migrat­
ing bands due to low molecular weight material were observed in these 
Met 
Figure 14: Polyacrylamide gel electrophoresis of purified FUra-substituted tRNAf under 
denaturing and non-denaturing conditions. 
(a) RNA samples were electrophoresed on 15% polyacrylamide gels prepared in 
buffer containing 7 M urea as described in Methods. Each lane contained 1 ^g 
Met Met 
of RNA. (1) FUra-tRNA£ (A)J (2) FUra-tRNA^ (B); (3) mixture of FUra-
Met Met Met 
tRNA£ (A) and FUra^ (B); (4) mixture of FUra-tRNAf (A) and normal 
Met Met Met 
tRNAf ; (5) mixture of FUra-tRNA^ (B) and normal tRNAf ; (6) normal 
Met 
tRNAf . 
(b) RNA samples were electrophoresed on 10% polyacrylamide gels prepared in 
the absence of urea. Each lane contained 1 ywg of RNA. (1) mixture of FUra-
Met Met Met Met 
tRNAf (A) and FUra^ (B); (2) FUraf (A); (3) FUra-tRNAj (B); (4) normal 
Met Met Met 
tRNA^ ; (5) mixture of FUra-tRNAf (A) and normal tRNA^ (6 ) mixtute of FUra-
Met, Met 
tRNAf (B) and normal tRNAf 
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experiments (results not shown). The electrophoresed behavior of the 
tRNAs was identical with or without the preheating step. 
When the tRNA^ s were electrophorested under non-denaturing 
conditions, i.e., in the absence of urea, normal tRNA^®*" migrated 
faster than FUra-substituted tRNAs (Figure 14b). The difference in 
migration between normal and FUra-substituted tRNAs was not as great 
as that observed in the presence of 7 M urea, and mixtures of normal 
tRNA^®^ and either species of FUra-tRNA^®*" could not be resolved by 
electrophoresis in the absence of urea. 
Rechromatography of renatured FUra-tRNA on BD-cellulose 
In order to determine the molecular basis for the separation of the 
two forms of FUra-substituted tRNA^®^ on BD-cellulose, several pos­
sible differences between these molecules were examined. The two 
species of tRNA could represent stable conformers, interconvertible 
by denaturation-renaturation. This behavior has been observed for sev-
His Try Glu 
era I E. coli tRNAs includirg tRNA , tRNA , and tRNA2 (Ishida 
et al. , 1971); however, it has not been observed for normal tRNA^^^. 
To examine this possibility, each FUra-tRNAj^®^ sample was denatured 
by heating solutions containing 60 Ag^g units RNA/mL in 10 mM Tris-
HCl, pH 7.5, 10 mM ED TA at 50^C for 10 min, MgC I2 was then added 
++ to a concentration of 20 mM (resulting in a free Mg concentration of 
83 
10 mM) and the RNA was allowed to renature by cooling slowly to room 
temperature. The renatured tRNAs were chromatographed on BD-
cellulose under conditions identical to those used for their preparation. 
As is shown in Figure 15, the chromatographic behavior of both forms 
of FUra-substituted initiator tRNA was unaffected by denaturation-re-
naturation. Renatured form (A), when chromatographed alone 
(Figure 15a), was eluted as a single peak at the same NaCl concentra­
tion as the original material. The behavior of form (B) also remained 
unchanged on rechromatography (Figure 15b). There was no evidence 
of interconversion between the two tRNAs as would be expected if they 
represented two stable conformers of the tRNA. The elution pattern of 
a mixture of the renatured tRNAs was the same as that observed on 
BD-cellulose with the original separation (compare Figure 15c and 
Figure 7). 
Met 
Analysis of the 3' terminus of FUra-substituted tRNAf 
Two experiments were performed to examine the possibility that 
Met 
the difference between forms (A) and (B) of FUra-substituted tRNA^ 
is due to the absence of all or part of the CCA-3' terminus in one 
species. If this were the only difference between the two forms of the 
tRNA, then the products of aminoacylation should have identical chroma­
tographic properties. The crude enzyme preparation used in the charg­
ing reaction contains the nucleotidyl transferase necessary for 
84 
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Figure 15: BD-cellulose chromatography of renatured FUra-substituted 
Met Met 
tRNAf . Samples of FUra-tBNAf (A) and (B) were heat 
denatured and then renatured as described in the text. These 
samples were then chromatographed on an analytical BD-
cellulose column under the conditions described in Methods. 
(a) FUra-tRNA^®^ (A); FUra-tRNAf^®^ (B); (c) mixture of 
forms (A) and (B). A260 (o—o); NaCl concentration (A-A). 
Met 
Figure 16; Chromatography of methionyl-FUra-tRNA^ on BD-cellulose. Forms (A) and (B) 
were separately charged with [^^c] and [^î^methionine, respectively. The amino-
acyl-tRNAs were mixed and cochromatographed on an analytical BD-cellulose column 
as described in Methods. The column was developed with a linear NaCl gradient 
from 0.4 M to 1.0 M. P^C^methionyl-tRNA^^' (A) (o o); (^hJ methionyl-tRNA^ 
(B) ((» #); NaCl concentration ( A A ). 
[J^C] Methionine, cpmxlO ^ (<>—o); pH] Methionine, cpmxlO-^ (•—•) 
ro oo 
oo 
0» 
« 
o s ro 
c 3 g-
oo 
[NaCi] (M) (2^) 
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repair of the 3' end so damaged tRNA would be repaired and then 
aminoacylated during the charging reaction. Subsequent removal of the 
methionine by hydrolysis of the ester linkage should not affect the 3' end 
of the tRNA. 
14 3 
Forms (A) and (B) were separately charged with C- and H-
l abeled methionine, respectively. The aminoacyl-tRNAs were re­
covered (See Methods), combined and chromatographed together on BD-
14 Met 
cellulose (Figure 16). C-labeled methionyl-tRNA^ (A) was eluted 
first followed by the H-labeled methionyl-tRNA^®^ (B). The two 
tENAs retained their different chromatographic behavior after aminocy-
lation. 
A similar experiment was performed using tRNAs that had been 
charged with methionine and then stripped. Form (A) chromato­
graphed as a single peak on BD-cellulose (Figure 17a). The salt concen­
tration at which the tRNA was eluted (0. 55 M) was the same as that at 
which form (A) eluted during the original preparation. Form (B) also 
appeared as a single peak eluting at the expected higher salt concentra­
tion, 0.59 M (Figure 17b). 
Nucleoside composition 
The nucleoside composition of the tRNA was determined by the 
3 
H derivative method (Randerath et al. , 1972; 1974) and by HPLC 
Figure 17; BD-cellulose chromatog raphy of FUra-substituted tRNAf 
The methionine-specific tRNAs were charged with methionine, 
then stripped and chromatographed on BD-cellulose. (a) 
FUra-tRNA^®' (A); (b) FUra-tRNA^®^ )B). Methionine 
acceptance activity ( # # ), A250 (o -o), and NaCl concen­
tration (x x). 
89 
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(Davis et al. , 1979). Figure 18 shows the two-dimensional separation 
of ^H-lafaeled digests of normal and FUra-substituted tRNAf^^^s. As 
Val 
was previously observed for FUra-substituted tRNA (Horowitz et al. , 
1974), almost all of the uridine and uridine-derived minor bases of the 
FUra-tRNAf s were replaced by 5-fluorouridine; the results are quan-
titated in Table 4. The composition found for normal tRNA^®^ was very 
close to that expected (-Dube et al., 1968). The FUra-substituted initia­
tor tRNAs had the same composition as normal tRNA^^^ except for the 
replacement of uridine, dihydrouridine, pseudouridine, and ribothy-
3 
midi ne by 5-fluorouridine. (The H-derivative method cannot be used 
to determine 4-thiouridine; it is converted to uridine in the course of 
the procedure. ) The FUra-tRNAs also contained small amounts (ca 
0.4 residues/molecule ) of 5-fluorocytidine. Replacement of uridine 
by FUra was 93% in FUra-tRNA^^ (A) and 89% in FUra-tRNAf^®^ (B). 
Met 
Norrrml tRNA^ contained the expected one 7-methylguanosine 
(m^Guo) per molecule and the FUra-substituted tRNAs contained about 80% 
7 
of the normal level. Since about one-third of the m Guo is degraded 
during the assay and a large correction factor must be applied to the 
data, this difference is probably not significant. However, analysis of 
a second preparation of FUra-substituted tRNAf^^^ also showed reduced 
7 
amonnts of m Guo in analog containing tRNAs (normal 0. 93 , FUra-
tRNA (A) 0.66 FUra-tRNA (B) 0.67). 
91 
4 Neither 4-thiouridine (s Urd) nor 2'-0-methylcytidine (Cm) can 
3 be determined by the H-derivative method of nucleoside analysis be-
4 
cause s "Urd is converted to uridine during the labeling procedure 
(Rande rath et al., 1972) and Cm can not be oxidized by periodate. HPLC 
was used to determine these two minor nucleosides as well as to con­
firm the results of ^H-derivative analysis. The preparation of samples 
for analysis by HPLC also results in some degradation of 4-thiouridine, 
and a correction is applied to the values (Davis et al. , 1979). The 
values for 4-thiouridine were a little low for the normal tRNA^®^ (0. 8 
residues instead of 1. 0 residue) and higher than expected for the FUra-
substituted tRNAs (0. 29 for form (A) and 0. 32 for form (B)). Both of the 
FUra-tRNAs contained Cm but it was less than the expected one residue 
of Cm per molecule (Table 4). 
The values obtained for the major nucleosides (Ado, Guo, Cyd, 
Urd, and FUrd) by either method of analysis were essentially the same. 
The two assay methods gave different values for m Guo. Only about 50% 
7 
of the expected amount of m Guo was found in any of the tRNAs by the 
HPL.C method (Table 4). Most differences in values between the two 
methods of analysis and most deviations from expected values were found 
in the data for the minor nucleosides. Some of these differences are no 
doubt due to the small amount of each nucleoside present in the tRNAs. 
Rgure 18; Two-dimensional TLC of H-labeled digests of tRNA^®'. RNA samples were hydro-
lyzed to nucleosides, oxidized with periodate, and then reduced with KBH^ as 
described under Methods. First dimension of chromatograph was from bottom to 
top; second dimension from left to right. Labeled nucleosides were visualized by 
fluorography. (a) normal (b) FUra-tRNA^®^ (A); (c) FUra-tRNAf^®^ (B). 
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Table 4: NucleoHide composition of normal and FUra-substituted tRNAf (residues per 
77 total) 
Nucleoside 
Normal tRNA 
H-deriv. HPLC 
FUra-tRNA (A) 
H-deriv. HPLC 
FUra-
H-deriv 
tRNA (B) 
HPLC Expected 
Ado 14. 1 14. 1 14.3 13. 8 14. 1 13. 7 14 
Guo 23.4 23.9 23. 0 24. 5 23.4 24. 2 24 
Cyd 25. 5 25.6 26.0 25. 5 25. 1 25. 1 25 
Urd 9. 05 8.2 0. 76 0.63 1 . 35 1.16 8  + 1 *  
FUrd - - 10.7 11. 0 10.6 11.2 (12) 
FCyd - - 0. 38 ND 0.41 ND 0 
Drd 1. 03 ND 0.08 ND 0. 10 ND 1 
rThd .0.96 1.02 0.02 0.01 0.05 0.03 1 
<&rd 0.89 1. 01 
00 o
 
o
 0. 13 0. 11 0. 05 1 
7 
m Guo 1. 01*^ . 5 1  0. 83*' 0.59 0.81^ 0.45 1 
s^Urd - a 0. 80 -a 0.29 -a 0. 32 1 
Cm ND 0. 91 ND 0.58 ND 0.75 1 
^4-Thi©uridine is recovered as uridine in the H labeling procedure. 
^Corrected for 64% recovery. 
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No major differences could be seen in the composition of forms 
M et (A) and (B). FUra-tRNAf (A) had a slightly higher Cyd and lower Guo 
"Met Met 
and Cm content than FUra-tRNA^ (B) or normal tRNA^ . Form (B) 
contained more Urd (but not less FUrd) than form (A) (Table 4). 
Met 
Oligonucleotide Maps of FUra-substituted tRNAf 
In order to examine the structural differences between FUra-sub-
Met 
stituted tRNA£ (A) and (B) in greater detail, oligonucleotide maps were 
prepared by thin layer chromatography of RNase -alkaline phosphatase 
hydrolyzates of the RNAs. After the tRNAs were digested with a mixture 
of ribonuclease T% and alkaline phosphatase, the 3'ends of the resulting 
oligonucleotides were labeled by oxidation with periodate and reduction 
with KBH4. The labeled oligonucleotides were separated by two-
dimensional TLC on PEI-cellulose sheets (Figure 19). As expected from 
Met Met 
the nucleoside composition, FUra-tRNAf (A), FUra-tRNAf (B), and 
Met 
normal tRNAf gave generally similar T^ fingerprints (Figure 19). 
Oligonucleotides containing FUra in place of uracil appeared to have 
about the same mobility as those without the analog. 
There were several clear differences between the maps of form 
Met (A) and form (B) of FUra-tRNAf . Oligonucleotide b observed on the 
Met 
map of FUra-tRNAf (B) was absent from that of form (A), A small 
spot designated a in the map of form (A) was not present in the map of 
(B). The pattern in the region of spots 11 and 12 had three oligonucleo­
tides (11, 12 and c) in the map of form (A) but only two (11 and 12) in 
the map of form (B). The two largest oligonucleotides, 13 and 14, mi­
grated very little under the chromatography conditions used. 
The number of copies of each 3'-end labeled oligonucleotide was 
determined by cutting out the spots and measuring the amount of radio­
activity in each. Table 5 lists the radioactivity found in each oligo­
nucleotide relative to that in oligonucleotide 4. Oligonucleotide 4 was 
chosen as the standard for comparison because it was well-separated 
from other spots and it was present on all three maps. Guanosine 
(9 residues/tRNA expected) is not found on the maps because it is lost 
in the methanol washes during the chromatography procedures. 
Based on the known sequence of tRNA^^^ (Figure 1), two oligonu­
cleotides should be present at twice the concentration of the others. 
CpG' and UpCpG' (FpCpC in Fura-substituted tRNA). CThe oligo­
nucleotides are marked with a prime to indicate that the 3' terminal 
nucleoside residue has been oxidized and reduced to the dialcohoU ) Two 
spots were found to contain about twice the radioactivity in spot 4; these 
were spots 1 and 5 (Table 5). Since mobility in the first dimension is 
determined primarily by the size of the oligonucleotide (Randerath 
et al. , 1980), spot 1, which moved the furthest (to the left on Figure 19) 
was probably the dinucleotide CpG' and spot 5 was FpCpG' or UpCpG'. 
Figure 19: Oligonucleotide maps of RNase Tj digests of tRNAf 
RNA samples were digested with, RNase and alkaline 
phosphatase, and the oligonucleotides were 3'-end labeled 
with titium as described in Methods. Fingerprints were 
prepared by two-dimensional TLC on PEI-cellulose (see 
text) and the labeled oligonucleotides were visualized by 
fluorography. First dimension chromatography (LiCl 
gradient was from right to left; second dimension (ammon­
ium formate gradient) from bottom to top. (a) normal tRNi^ 
(b) FUra-tRNA^®^ (A); (c) FUra-tRNA^®^ (B). 
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Spots 13 and 14 overlapped each other and the origin which may ac­
count for the variation of their values from the expected value of one 
fragment per molecule. Oligonucleotides g and 5 on the map of normal 
tRNA£ and oligonucleotides 7 and 8 on the maps of all three tENAs also 
overlapped. Several spots were present in less than one copy per mole-
Met 
cule. These included: c, d, e, f, 11, 12 in normal tKNAf ; a, c, d, 
e, 11, 12 in FUra-tRNA^®^ (A); and d, 11, 12 in FUra-tRNA^®^ (B) 
(Table 5). Some of this may be due to incomplete digestion. The pres­
ence of less than one copy per molecule of some spots may indicate that 
the tRNA samples were heterogeneous. For example, if the normal 
Met 
tRNAf sample contains the minor varient with Ado at position 46 in 
7 7 
place of m Guo, then ApUpCpG' as well as m GpUpCpG' would be present 
in the T| digest and the sum of their relative concentrations would be 
one. Some of the spots may simply be due to radioactive contaminants. 
To determine the composition of each nucleotide, the spots were 
eluted from the chromatograms and their composition determined by the 
3 
H-derivative method after hydrolysis to the constituent nucleosides 
(see Methods). Unfortunately» impurities introduced during the elution 
process interfered with the analysis and made interpretation of the re­
sults- difficult. In addition to high levels of labeled background material, 
the nucleosides were not labeled uniformly. The 3' end of each oligo­
nucleotide (Guo in all cases except for Ado from the 3' end of the intact 
Table 5; Composition of oligonucleotides from RNase -alkaline phosphatase fingerprints. 
Met Met 
normal tRNAf FUra -substituted tRNAf 
oligo-
nucleo- tentative (A) (B) tentative 
tide rel identi- rel rel identi-
number amt^ fication amt^ comp^ amt^ comp^ fication^ 
1 1.77 CG 
2 0.63 s'^UG 
3 0. 86 AG 
4 (1.00) CAG 
e 
0. 12 
0. 50 
g 1.52 DAG 
5 1.85 UCG 
6 0.77 AAG 
1.99 ND 
0.93 G 
0.71 ND 
(1.00) ND 
0.34 A,G 
0.20 ND 
0.13 C,G 
1.94 ND 
0.96 P,G 
0.81 ND 
(1.00) ND 
1.11 A,F,G 
0. 24 ND 
1.94 A,C,F,G 1.94 C,F,G 
0.66 A,F,G 0.66 A,G 
CG 
FG 
AG 
CAG 
FAG 
FCG 
AAG 
7 
8 
9 
10 
11 
12  
c 
f 
13 
14 
1 . 2 3  I  C C U G  
1. 09j CUCG 
0 . 7 1  C C C C C G  
0 . 6 9  C A A C C A  
' I .  0. 22 \ m GUCG 
0. 17 AUG G 
0. 22 
0.36 T tl» CAAAU.CC G 
1. 13 ND 1. 08 ND f CCFG 
1. 17 ND 1. 06 ND C.CFCG 
1. 26 A,C 0. 75 A,C CCCCCG 
0.95 A,C, G 0. 69 .G,G CAACCA 
0.59 A,C, F, G 0. 50 A,C, F, G. U ^ÏÏJGFCG 
0.47 A,C, F, G 0» 58 A.C, F. G. U •s or 
0.69 A,C, G, U - - f AFCG 
0.56 ND 
0.65 CmUCAUAACCCG 1.35 ND 
0. 34 ND 
0.81 ND 
FFCAAAFCCG 
CmFCAFAACCCG 
'^Determined by measuring radioactivity of each oligonucleotide spot. Expressed relative to 
spot 4 (=1. 00). 
^By comparison to published fingerprints of normal tRNA^^^ (Chen and Roe, 1978), 
"^Determined by elution of oligonucleotide spots and analysis by ^H-derivative method. Results 
listed alphabetically. 
^Based on ^H derivative assay of eluted spots and comparison to published fingerprints. 
102 
tRNA) was tritium labeled prior to the separation of the oligonucleotide 
by TLC. Other residues in each oligonucleotide were labeled after the 
oligonucleotide was extracted from the chromatogram and hydolyzed. 
The amount of label incorporated in this step was usually much lower than 
that introduced in the first step, possibly due to the presence of phospho-
cellulose and other impurities which were extracted from the chromato­
graphic plate along with the oligonucleotide. For example, spot 2 
(Figure 10) was assumed to be FpG' (s^UpG' in normal tRNA^^^), When 
spot 2 from the fingerprint of FUra-tRNA^®' form (B) was analyzed, 
FUrd and Guo were found, but when the same spot from the fingerprint 
of (A) was examined, only Guo was found (Table 5). The amount of FUrd 
in spot 2 from (B) appeared to be much less than the amount of Guo. 
The composition of those oligonucleotides which could be deter­
mined is given in Table 5. Only oligonucleotides from FUra-substituted 
tSNA^®^ were examined. Fragment b of FUra-tRNA^®^ (B) was identi-
fied as FpApG' (DpApG' in normal tRNAf ) which is found in the dihy-
drouridine loop (residues 20 - 22). No oligonucleotide with composi­
tion FpApG' or DpApG' was found in FUra-tRNA^^^ (A). The small 
spot, a, found only on the map of (A) contained Ado and Guo but its iden­
tity could not be determined. 
The relative concentration of the oligonucleotides and comparison 
of the maps to published RNase T^-alkaline phosphatase fingerprints of 
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Met 
normal tRNAf (Chen and Roe, 1978) and other tRNAs (Randerath et 
al., 1980) allowed tentative identification of many of the fragments. 
These are listed on Table 5. 
The spots in the region of spot 11 were expected to include the 
7 7 
oligonucleotide m GpFpCpG' (residues 46 - 49). However, m Guo was 
not found in any of the oligonucleotides assayed (Table 5). Analysis of 
Met 
the nucleoside composition of intact FUra-substituted tRNAf had 
7 
shown m Guo to be present (Table 4) in both forms of the tRNA. The 
inability to find this minor nucleoside in any of the RNase T^-alkaline 
phosphatase-derived oligonucleotides may be due to its degradation. 
7 
As noted in Methods, m Guo is unstable under the conditions used in 
the tritium-derivative method of nucleoside analysis (Randerath et al., 
1972). In the course of analyzing the composition of oligonucleotides 
separated by TLC, the samples were exposed to this procedure twice, 
first to label the 3' end for TLC and then following complete hydrolysis 
7 to label the individual nucleosides, m Guo may have been present in one 
of the oligonucleotides, but was undetected because much of it was de­
graded during analysis. Three of the oligonucleotides in this region, c 
from form (A) and 11 and 12 from iorrïi (B), contained uridine in addition 
to 5-fluorouridine. 
The other oligonucleotides analyzed (2, 5, 6, 9, and 10) were found 
• . . Met 
in both species of FUra-tRNAf . As can be seen by examining the 
104 
results on Table 5, there was moderate agreement between the composi­
tion found by the analysis of the spots and the composition expected 
based on the published fingerprint of normal tRNA^^^. 
19 
F NMR of FUra-Substituted Initiator tRNA 
One purpose of obtaining pure FUra-substituted tRNAs was to use 
19 F NMR to study conformation of tRNA in solution and the interactions 
of proteins with tRNA. As a first step in this direction, the ^^F NMR 
Met 
spectra of the two forms of FUra£ were obtained. 
The spectra were recorded at 169 MHz in FT mode (Figure 20) 
with the sample dissolved in 30 mM sodium cacodylate, pH 7.2, 80 mM 
NaCl, 1 mM ED TA, and 10 mM MgCl2. The spectrum of form (A) con­
tained 7 well-resolved resonances and that of form (B) contained 9 res­
onances. The two spectra were similar except for additional res­
onances at 5. 2 and 7. 1 ppm downfield from 5-fluorouracil observed in the 
spectrum of form (B). Assignment of the resonances to the 12 5-
Met 
fluorouridines present in FUra-substituted tRNA£ will require further 
experiments. 
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T T T T I 1 I I I I & . . , . 
10 5 0 
PPM 
Figure 20: ^F NMR of FUra-substituted tRNA^®^ NMR spectra 
were recorded at 169 MHz in FT mode, on a Bruker WH-
180 spectrometer as described in Methods. The chemical 
shifts are in part per million from 5-fluorouracil. (a) 
Met Met 
FUra-tRNAf (A), 9729 scans; (b) FUra-tRNAf 
(B) 18,554 scans. 
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DISCUSSION 
Met 
E. coli FUra- substituted tENAf was purified by a series of 
chromatographic steps, first on DEAE-cellulose at pH 8.9, followed by 
Sepharose 4B using a reverse salt gradient, then DEAE Sepharose A-50, 
and finally BD-cellulose. The last step resolved two forms of FUra-
tRNAf , designated (A) and (3). Both species of FUra-tRNA^®^ had 
about 90% of the uridine and uridine-derived modified nucleosides re­
placed by fluorouridine. 
The purification of FUra-substituted initiator methionine tRNA 
was more difficult than expected. The chromatographic behavior of the 
analog- containing tRNA^^' was sufficiently different from that of normal 
tRNAf to require major modification in the usual purification proce­
dure (Nishimura, 1971) which consists of chromatography on DEAE-
Sephadex A-50 followed by chromatography on BD-cellulose. Separa­
tion of N-phenoxyacetylaminoacyl-tRNA from uncharged tRNAs on 
BD-cellulose (Gillam et al. , 1968) has been successfully used to purify 
FUra-substituted valine tRNA (Horowitz et al. , 1974), but attempts to 
use this method to purify FUra-substituted methionine tRNA were un­
satisfactory because of large losses of methionine accepting activity. 
Other methods that were tried but did not work include; chromatography 
of methionyl-tRNAf on dihydroxyboryl cellulose (McCutchen et al. , 
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1975); separation on an amine-coated Sephadex column (Nowak et al., 
1979), and chromatography of N-(£-chloromercuribenzenesulfonyl) 
methionyl-tRNA on a sulfhydryl resin (Go s s and Parkhurst, 1978). 
Met 
The FUra-substituted tRNAf species that were recovered by 
the four-step procedure described in Methods were highly purified. Both 
Met 
forms of tRNAf had specific activities of about 1600 pmole/A2^o 
(Table la) and electrophoresed as single bands (Figure 8, lanes 5 and 
6). The close agreement between the nucleoside composition of the 
FUra-tRNAs and the known composition of tRNA^®^ (Table 4) was, 
further evidence of the purity of the molecules. 
Met 
The FUra-substituted tRNA^ was not completely purified us­
ing the methods used for the purification of FUra-substituted initiator 
methionine tRNA (Table 2). Little purification was achieved by chroma­
tography on DEAE-Sephadex A-50 (Figure 10); however, the poor results 
were in part due to technical problems and poor choice of gradient con­
ditions. Chromatography of partially-purified FUra-tRNA^®' on BD-
cellulose resolved two methionine accepting peaks. Although these two 
FUra-substituted tRNA^** species may correspond to the two normal 
tRNA^ isoacceptors that can be separated on BD-cellulose (Nishimura, 
I97I), they may differ in the same manner that the two FUra-tRNAf^®^ 
species differ from each other. As will be discussed below, one form 
of FUra-tRNAf appears to contain a modified fluorouridine residue 
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(Gotten and Horowitz, personal communication. Dept. of Biochemistry, 
Iowa State Univ). The same modification may also occur in a portion of 
the FUra-tRNA_ . 
m 
Met 
The FUra-substituted tRNA^ could be aminoacylated and com­
pletely formylated which indicates that the substitution of 5-fluorouri-
dine for uridine and uridine-de rived nucleosides did not interfere with 
recognition by either the methionyl-tRNA synthetase or the transformy-
lase. As discussed in the Introduction, this is consistent with the results 
of studies on aminoacylation of unfractionated FUra - substituted tRNA. 
More detailed comparison of the aminoacylation of normal and FUra-
Met 
substituted tRNAf showed that the KCI and magnesium ion concentra­
tions needed for optimal reaction velocity were the same. The apparent 
Km s were essentially the same for the two forms of FUra-tRNAf^®^, 
and these values were similar but slightly lower than the calcu-
Met 
lated for the normal tRNAf (Table 3). The maximum velocity ob­
tained with either analog-containing tRNA was lower than the velocity with 
Met 
normal tRNAf 
There are two isoaccepting species of initiator tRNA found in 
Met 
E. coli (Dube et al., 1968); the major species, designated tENAfj^ 
7 (Egan et al., 1973), has m Quo at position 46 while the minor species. 
Met 
tRNAf3 , has Ado (Figure Ic). Examination of the results of the 
nucleoside analysis ( Table 4) clearly shows that the two forms of FUra-
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Met 
substituted tRNA^ cannot be equivalent to the major and minor species 
Met 7 
of normal tRNAf since both FUra-substituted forms contained m Guo. 
Recently, M. Gotten and J* Horowitz (personal communication. Dept. of 
Biochemistry, Iowa State Univ. ) have succeeded in separating both form (A) 
and form (B) into two fractions on RPC-3 (Weeren et al. , 1972) that cor-
Met Met 
respond to normal tRNAfj and tRNA^g . The presence of both species 
of initiator tRNA in both form (A) and form (B) of FUra-tRNA^®^ would 
7 
account for m Guo being present at less than one residue per tRNA 
molecule in both FUra-substituted tRNAs (Table 4). The presence of 
both the major and minor isoacceptors would also be consistent with the 
multiple spots observed on the RNase T^ oligonucleotide maps in the 
7 
region where the oligonucleotide m GpFpCpG' was expected (Figure 19, 
Table 5). 
Leu Trp Gly 
Several tRNAs, including tRNAg , tRNA , and tRNA^ , can 
exist in two stable conformations at neutral pK {Ishida et al. , 1971). 
Only one of the conformations can be aminoacylated. The inactive-de­
natured conformation can be converted to the active-native conformation 
by heating to 40°C to 60°C, depending on the RNA, and then cooling 
slowly in the presence of Mg^^. Although this behavior has not been ob-
, , Met 
served for normal tRNA^ , the substitution of FUrd for uridine might 
allow the formation of a second stable conformation of FUra-tRNAf 
No evidence of interconversion of conformer s was observed when forms 
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(A) and (B) of FUra-substituted tRNA^ were denatured by heating and 
then renatured (Figure 15). The chromatographic behavior of both 
tRNAs on BD-cellulose was unchanged by the treatment, eliminating the 
possibility that the two are conformera. 
The CCA-3' terminus of both form (A) and form (B) was found 
to be intact. If one form of FUra-substituted tRNAf differed from the 
other by the absence of all or part of the three nucleosides at the 3' end, 
the incomplete tRNA would have been repaired when charged with methio­
nine and the two forms would then be identical. This was clearly not the 
case since forms (A) and (B) were still resolved on BD-cellulose after 
charging (Figure 16) and after charging and stripping (Figure 17). 
Electrophoresis of the FUra-substituted tRNAs indicated that both 
Met 
form (A) and form (B) might be larger than normal tRNA^ since both 
Met 
migrated more slowly than normal tRNA£ even when denatured 
(Figure 14). The presence of FUrd residues in the primary transcrip­
tion product might prevent complete processing of FUra-substituted 
tRNA. As mentioned in the Introduction, FUra-substituted eukaryotic 
rRNA is not processed normally. Incomplete processing could result 
in extra nucleotides at either terminus of the tRNA. Since both forms of 
FUra-fcRNAf were readily aminoacylated, it is unlikely that the 3' 
terminus contained extra nucleotides. 
111a 
Oligonucleotide maps of the two forms of FUra-substituted tENA^ 
did not provide any evidence that either form was incompletely pro­
cessed. Examination of the sequence of tRNA^®^ (Figure Ic) shows that 
RNase Tl-alkaline phosphatase digestion would result in the release of 2 
moles CpG'/mole of RNA, one of which is from the 5' terminus. The 
oligonucleotide maps (Figure 19) of normal tRNA^^^ and both forms of 
Met 
FUra-tRNAf contained a spot (1) that was identified as the dinucleo­
tide CpG' and that was present at twice the concentration of other 
oligonucleotides (Table 5). However, the presence of this dinucleo-
tide at the correct concentration does not eliminate the possibility of ad­
ditional nucleotides at the 5' end of the tRNA. A sequence ending in G 
could have been cleaved from the 5' terminus, and the presence of such 
an oligonucleotide could not be ruled out without sequencing all of the 
oligonucleotide spots. 
An oligonucleotide with the composition CpApApCpCpA' is re­
leased from the 3' terminus by RNase Tj^-alkaline phosphatase digestion. 
Spot 9, which migrated at a rate appropriate for a hexanucleotide 
(Figure 18) and contained only Ado and Cyd (Table 5), was identified 
as the 3'-terminal sequence and was present in both FUra-substituted 
Met Met 
tRNAf s as well as in normal tRNAf . The presence of fluorouri-
dine in place of uridine and uridine-derived modified nucleosides does 
not appear to interfere with the processing of tRNAf at the 3' terminus. 
111b 
Analysis of RNase Tj-alkaline phosphatase digests of FUra-
Met 
substituted tRNAf s showed form (B) to contain an oligonucleotide, b, 
that was absent from form (A) (Figure 19). Oligonucleotide b was 
identified as FpApG' (DpApG' in normal tRNAf ) which is located at 
positions 20 - 22 in the D arm. A spot labeled a was found only on the 
Met 
map of FUra-substituted tRNAf (A). It was present at the level of 
0. 3 residues/molecule and was composed of Ado and Guo only. Recent 
experiments by Gotten and Horowitz (personal communication. Dept. of 
Biochemistry, Iowa State Univ. ) show the difference between the two 
Met 
forms of FUra-substituted tRNAf to be at position 20 in the D loop 
(Drd in normal tRNAf ). While form (B) contains the expected 
fluorouridine residue at this position, form (A) appears to contain a modi­
fied fluorouridine. Their evidence suggests that the fluorouridine at 
position 20 in form (A) is probably reduced to fluorodihydrouridine in 
vivo, but the modified fluoropyrimidine is degraded to an open-ring com­
pound during the prolonged exposure to pH 8. 9 necessary during fractiona­
tion on DEAE-cellulose. The oligonucleotide labeled a, found only on the 
map of form (A), may contain the residues from position 20 - 22, includ­
ing the modified fluorouridine. Analysis of the oligonucleotide showed it 
to contain the other two residues that would be expected. Ado and Guo 
(Table 5). 
112a 
The F NMR spectra of the two forms of FUra-substituted tENA^ 
are similar except for the presence of resonances at 5. 2 and 7.1 ppm 
downfield from FUra in the spectrum of form (B) (Figure 20). Gotten 
and Horowitz (personal communication. Dept. of Biochemistry, Iowa 
State Univ. ) have tentitively assigned the resonance at 5. 2 ppm to the 
FUrd at position 20 in form (B) that is missing in form (A). They have 
found an additional peak far upfield in the spectrum of form (A) at 
about -15 ppm. Their results indicate that this resonance is probably 
due to the open-ring nucleoside mentioned previously that would be 
formed from 5-fluoro-5, 6-dihydrouridine when the tRNA is exposed to 
high pH such as during the first chromatographic step. The spectrum 
of unfractionated tRNA from FUra-treated E. coli (never exposed to 
high pH) contained no peak at -15 ppm but did contain a peak at -32-33 
ppm which is characteristic of fluorodihydrouridine derivatives having 
a proton at position 5. Incubation of this tRNA at pH 8.9 resulted in the 
disappearance of the -33 ppm resonance and the appearance of the reso­
nance at -15 ppm. 
The appearance of a spectrum in the downfield region around 6-8 
ppm has been found to be very dependent on solvent conditions (Horowitz 
and Harden, personal communication. Dept. of Biochemistry, Iowa State 
Univ. ). Four peaks can be resolved between 6 and 8 ppm in the spectrum 
112b 
of form (A) when it is run at pH 6. 0 in 10 mM NaCl; whereas, only 
two are resolved at pH 7. 0 in 80 mM NaCl (Figure 20a). 
The overall appearance of the spectra of both forms of FUra-
Met 
substituted tRNAf is similar to that of the spectra of FUra-substi-
Val tuted tRNA (Horowitz et al. , 1977) and of unfractionated FUra-
tRNA (Cohn et al. , 1981). There is a strong peak at 5 ppm which has 
tentitively been attributed to non-hydrogen bonded FUrd residues (see 
Introduction). There is a group of 3 or 4 resonances downfield from the 
peak at 5 ppm and another group of 3 resonances upfield from the 5 ppm 
peak. Assignment of these resonances to specific FUrd residues in 
Met 
FUra-substituted tRNAf will require much more experimentation. 
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